Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ybx1
|
ENSMUSG00000028639.8 | Y box protein 1 |
Nfya
|
ENSMUSG00000023994.7 | nuclear transcription factor-Y alpha |
Nfyb
|
ENSMUSG00000020248.12 | nuclear transcription factor-Y beta |
Nfyc
|
ENSMUSG00000032897.11 | nuclear transcription factor-Y gamma |
Cebpz
|
ENSMUSG00000024081.8 | CCAAT/enhancer binding protein zeta |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_78936552_78936933 | Cebpz | 295 | 0.562515 | 0.37 | 5.9e-03 | Click! |
chr17_48409467_48409885 | Nfya | 12 | 0.828901 | 0.81 | 1.2e-13 | Click! |
chr17_48404919_48405078 | Nfya | 4454 | 0.127434 | 0.79 | 6.8e-13 | Click! |
chr17_48407206_48407440 | Nfya | 2365 | 0.168985 | 0.78 | 1.4e-12 | Click! |
chr17_48407639_48407792 | Nfya | 1973 | 0.191142 | 0.78 | 2.9e-12 | Click! |
chr17_48409030_48409309 | Nfya | 519 | 0.532595 | 0.77 | 4.3e-12 | Click! |
chr10_82763647_82764348 | Nfyb | 104 | 0.947333 | 0.88 | 2.5e-18 | Click! |
chr10_82759011_82759171 | Nfyb | 1784 | 0.246926 | 0.82 | 3.5e-14 | Click! |
chr10_82754764_82754915 | Nfyb | 2289 | 0.204262 | 0.72 | 4.5e-10 | Click! |
chr10_82764375_82764727 | Nfyb | 407 | 0.765948 | 0.64 | 1.6e-07 | Click! |
chr10_82758819_82758970 | Nfyb | 1587 | 0.274407 | 0.64 | 1.7e-07 | Click! |
chr4_120825189_120825394 | Nfyc | 393 | 0.781241 | 0.85 | 3.3e-16 | Click! |
chr4_120825669_120825856 | Nfyc | 55 | 0.959892 | 0.82 | 2.3e-14 | Click! |
chr4_120816055_120816232 | Nfyc | 431 | 0.754573 | 0.72 | 4.2e-10 | Click! |
chr4_120815702_120815893 | Nfyc | 85 | 0.953958 | 0.67 | 1.7e-08 | Click! |
chr4_120824866_120825176 | Nfyc | 663 | 0.592166 | 0.67 | 2.0e-08 | Click! |
chr4_119294357_119295020 | Ybx1 | 84 | 0.897668 | 0.79 | 1.3e-12 | Click! |
chr4_119293835_119294347 | Ybx1 | 389 | 0.681055 | 0.69 | 4.8e-09 | Click! |
chr4_119292829_119293025 | Ybx1 | 1553 | 0.206700 | 0.55 | 1.1e-05 | Click! |
chr4_119285471_119285628 | Ybx1 | 2757 | 0.131878 | 0.36 | 6.5e-03 | Click! |
chr4_119284979_119285144 | Ybx1 | 2269 | 0.151492 | 0.03 | 8.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_121447162_121447357 | 65.35 |
Gm33299 |
predicted gene, 33299 |
8503 |
0.19 |
chr11_116307894_116308091 | 62.25 |
Exoc7 |
exocyst complex component 7 |
759 |
0.46 |
chr2_165884402_165885933 | 55.75 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr12_30922517_30922677 | 53.12 |
Sh3yl1 |
Sh3 domain YSC-like 1 |
10410 |
0.17 |
chr11_87108685_87109095 | 47.83 |
Prr11 |
proline rich 11 |
182 |
0.66 |
chr7_4739300_4740219 | 46.60 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr6_49209060_49209253 | 46.52 |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
5005 |
0.17 |
chr2_164769553_164770281 | 44.87 |
Ube2c |
ubiquitin-conjugating enzyme E2C |
14 |
0.75 |
chr11_116024414_116024839 | 44.59 |
H3f3b |
H3.3 histone B |
112 |
0.93 |
chr11_55469143_55469734 | 42.75 |
G3bp1 |
GTPase activating protein (SH3 domain) binding protein 1 |
247 |
0.86 |
chr15_79062847_79063320 | 41.65 |
Ankrd54 |
ankyrin repeat domain 54 |
190 |
0.84 |
chr11_100938783_100940230 | 41.33 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr4_116720426_116721428 | 39.59 |
Tesk2 |
testis-specific kinase 2 |
21 |
0.96 |
chr16_38088667_38089060 | 39.37 |
Gsk3b |
glycogen synthase kinase 3 beta |
138 |
0.97 |
chr11_121237032_121237764 | 39.06 |
Narf |
nuclear prelamin A recognition factor |
145 |
0.93 |
chr3_32708239_32708713 | 38.01 |
Actl6a |
actin-like 6A |
31 |
0.97 |
chr18_77806908_77807079 | 37.89 |
F830208F22Rik |
RIKEN cDNA F830208F22 gene |
10250 |
0.15 |
chr5_130144379_130144620 | 36.38 |
Kctd7 |
potassium channel tetramerisation domain containing 7 |
362 |
0.79 |
chr2_152406114_152406779 | 35.47 |
Sox12 |
SRY (sex determining region Y)-box 12 |
8383 |
0.08 |
chr11_96943726_96944317 | 35.15 |
Pnpo |
pyridoxine 5'-phosphate oxidase |
35 |
0.62 |
chr18_42510920_42511513 | 35.12 |
Tcerg1 |
transcription elongation regulator 1 (CA150) |
271 |
0.91 |
chr15_103239260_103239668 | 34.79 |
Cbx5 |
chromobox 5 |
352 |
0.7 |
chr7_113513044_113513931 | 34.38 |
Far1 |
fatty acyl CoA reductase 1 |
347 |
0.88 |
chr5_137684632_137685345 | 34.35 |
Agfg2 |
ArfGAP with FG repeats 2 |
262 |
0.81 |
chr5_143732414_143732623 | 34.07 |
Usp42 |
ubiquitin specific peptidase 42 |
238 |
0.92 |
chr2_30392015_30392439 | 33.91 |
Dolpp1 |
dolichyl pyrophosphate phosphatase 1 |
27 |
0.95 |
chr7_24852964_24853147 | 33.76 |
Gm18207 |
predicted gene, 18207 |
7891 |
0.09 |
chr19_4097063_4097472 | 33.16 |
Cdk2ap2 |
CDK2-associated protein 2 |
85 |
0.9 |
chr1_180195982_180196192 | 32.95 |
Coq8a |
coenzyme Q8A |
12 |
0.97 |
chr12_71015615_71016046 | 32.79 |
3110056K07Rik |
RIKEN cDNA 3110056K07 gene |
2 |
0.67 |
chr8_18846118_18846603 | 32.58 |
Agpat5 |
1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon) |
81 |
0.97 |
chr7_48880950_48881793 | 31.92 |
Gm2788 |
predicted gene 2788 |
71 |
0.71 |
chr12_111813927_111814649 | 31.78 |
Zfyve21 |
zinc finger, FYVE domain containing 21 |
47 |
0.85 |
chr11_71019250_71019687 | 31.63 |
Mis12 |
MIS12 kinetochore complex component |
143 |
0.51 |
chr12_100725043_100725700 | 31.35 |
Rps6ka5 |
ribosomal protein S6 kinase, polypeptide 5 |
251 |
0.91 |
chr4_151861786_151862239 | 31.19 |
Camta1 |
calmodulin binding transcription activator 1 |
136 |
0.97 |
chr6_125573315_125573505 | 31.12 |
Vwf |
Von Willebrand factor |
7159 |
0.22 |
chr1_139454406_139454806 | 31.06 |
Aspm |
abnormal spindle microtubule assembly |
166 |
0.95 |
chr11_116433773_116434215 | 30.79 |
Ubald2 |
UBA-like domain containing 2 |
100 |
0.94 |
chr10_40125174_40125635 | 30.38 |
Gm25613 |
predicted gene, 25613 |
15942 |
0.13 |
chr11_58641727_58641891 | 30.03 |
Trim58 |
tripartite motif-containing 58 |
1344 |
0.21 |
chr4_43000389_43000942 | 29.90 |
Vcp |
valosin containing protein |
158 |
0.91 |
chr1_160061363_160061635 | 29.16 |
4930523C07Rik |
RIKEN cDNA 4930523C07 gene |
13663 |
0.15 |
chr4_132515167_132515846 | 29.05 |
Sesn2 |
sestrin 2 |
5005 |
0.1 |
chr4_139622692_139622866 | 28.86 |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
87 |
0.96 |
chr3_100438511_100438708 | 28.58 |
Gm43121 |
predicted gene 43121 |
775 |
0.58 |
chr6_136553811_136554042 | 28.50 |
Atf7ip |
activating transcription factor 7 interacting protein |
78 |
0.97 |
chr12_108292459_108292769 | 27.81 |
Hhipl1 |
hedgehog interacting protein-like 1 |
13656 |
0.15 |
chr3_144670557_144670708 | 27.78 |
Sh3glb1 |
SH3-domain GRB2-like B1 (endophilin) |
26835 |
0.13 |
chr1_134099064_134099493 | 27.70 |
Gm38140 |
predicted gene, 38140 |
119 |
0.94 |
chr9_111271464_111271944 | 27.43 |
Mlh1 |
mutL homolog 1 |
87 |
0.69 |
chr3_95588654_95589008 | 27.24 |
Golph3l |
golgi phosphoprotein 3-like |
103 |
0.54 |
chr11_32296147_32296690 | 27.20 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
71 |
0.95 |
chr11_32283463_32283827 | 26.96 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
134 |
0.92 |
chr11_120304745_120305917 | 26.88 |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
15538 |
0.09 |
chr17_84956946_84957394 | 26.59 |
1110020A21Rik |
RIKEN cDNA 1110020A21 gene |
69 |
0.86 |
chr4_136285851_136286405 | 26.55 |
Zfp46 |
zinc finger protein 46 |
24 |
0.97 |
chr11_23255157_23256431 | 26.47 |
Xpo1 |
exportin 1 |
247 |
0.94 |
chr5_149137148_149137325 | 26.43 |
Gm42788 |
predicted gene 42788 |
7027 |
0.1 |
chr13_95671190_95671369 | 26.16 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
240 |
0.9 |
chr13_101551260_101551432 | 25.90 |
Gm41043 |
predicted gene, 41043 |
3194 |
0.21 |
chr17_24850316_24850553 | 25.75 |
Hagh |
hydroxyacyl glutathione hydrolase |
56 |
0.5 |
chr16_22857502_22858351 | 25.69 |
Dnajb11 |
DnaJ heat shock protein family (Hsp40) member B11 |
60 |
0.75 |
chrX_71555732_71556091 | 25.59 |
Hmgb3 |
high mobility group box 3 |
7 |
0.98 |
chr7_141215165_141215936 | 25.56 |
Rassf7 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
310 |
0.71 |
chr11_68967971_68968166 | 25.47 |
Slc25a35 |
solute carrier family 25, member 35 |
63 |
0.93 |
chr15_78173996_78174525 | 25.45 |
Ift27 |
intraflagellar transport 27 |
153 |
0.56 |
chr11_102375874_102376188 | 25.41 |
Bloodlinc |
Bloodlinc, erythroid developmental long intergenic non-protein coding transcript |
989 |
0.36 |
chr10_85127631_85128502 | 25.40 |
Mterf2 |
mitochondrial transcription termination factor 2 |
39 |
0.97 |
chr3_138613710_138614127 | 25.32 |
Gm6057 |
predicted gene 6057 |
8934 |
0.14 |
chr8_83955381_83955773 | 25.24 |
Asf1b |
anti-silencing function 1B histone chaperone |
70 |
0.7 |
chr11_54860143_54861186 | 25.20 |
Lyrm7 |
LYR motif containing 7 |
55 |
0.96 |
chr19_6046317_6046652 | 25.10 |
Syvn1 |
synovial apoptosis inhibitor 1, synoviolin |
92 |
0.87 |
chr9_70834749_70835115 | 25.01 |
Gm3436 |
predicted pseudogene 3436 |
17644 |
0.18 |
chrX_106011700_106012118 | 24.99 |
Magt1 |
magnesium transporter 1 |
3 |
0.97 |
chr1_156745548_156745740 | 24.98 |
Fam20b |
family with sequence similarity 20, member B |
26558 |
0.14 |
chr11_87109120_87109288 | 24.75 |
Ska2 |
spindle and kinetochore associated complex subunit 2 |
30 |
0.88 |
chr5_149052675_149053358 | 24.71 |
Hmgb1 |
high mobility group box 1 |
0 |
0.96 |
chr2_127270090_127270274 | 24.61 |
Stard7 |
START domain containing 7 |
36 |
0.61 |
chr8_107402774_107403333 | 24.61 |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
153 |
0.94 |
chr14_67715692_67716236 | 24.49 |
Kctd9 |
potassium channel tetramerisation domain containing 9 |
27 |
0.61 |
chr1_180903101_180903294 | 24.42 |
Pycr2 |
pyrroline-5-carboxylate reductase family, member 2 |
1096 |
0.32 |
chr11_90666962_90667172 | 24.40 |
Tom1l1 |
target of myb1-like 1 (chicken) |
3755 |
0.24 |
chr5_123141048_123141487 | 24.32 |
AI480526 |
expressed sequence AI480526 |
178 |
0.82 |
chr19_44293374_44294099 | 24.29 |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
62 |
0.95 |
chr1_15805353_15805684 | 24.19 |
Terf1 |
telomeric repeat binding factor 1 |
128 |
0.96 |
chr6_47812781_47813882 | 24.13 |
Pdia4 |
protein disulfide isomerase associated 4 |
33 |
0.95 |
chr6_70844059_70844596 | 23.91 |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
188 |
0.93 |
chr11_78073909_78074294 | 23.85 |
Mir451b |
microRNA 451b |
860 |
0.24 |
chr9_121285724_121286056 | 23.71 |
Gm34655 |
predicted gene, 34655 |
8114 |
0.14 |
chr7_28810240_28811015 | 23.68 |
Gm44702 |
predicted gene 44702 |
130 |
0.65 |
chr5_92042627_92042822 | 23.64 |
Cdkl2 |
cyclin-dependent kinase-like 2 (CDC2-related kinase) |
28 |
0.97 |
chr8_64733589_64733990 | 23.55 |
Msmo1 |
methylsterol monoxygenase 1 |
3 |
0.97 |
chr13_23745111_23745731 | 23.52 |
H3c3 |
H3 clustered histone 3 |
181 |
0.69 |
chr5_124439753_124440600 | 23.42 |
Kmt5a |
lysine methyltransferase 5A |
191 |
0.89 |
chr9_70421473_70421676 | 23.39 |
Ccnb2 |
cyclin B2 |
27 |
0.97 |
chr17_63863664_63864059 | 23.39 |
A930002H24Rik |
RIKEN cDNA A930002H24 gene |
70 |
0.62 |
chr1_86525613_86527056 | 23.21 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr2_118901250_118901464 | 23.08 |
Bahd1 |
bromo adjacent homology domain containing 1 |
96 |
0.96 |
chr18_34651671_34652040 | 22.94 |
Cdc23 |
CDC23 cell division cycle 23 |
120 |
0.94 |
chr4_133872994_133873306 | 22.93 |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
111 |
0.88 |
chr11_4186299_4186825 | 22.85 |
Tbc1d10a |
TBC1 domain family, member 10a |
227 |
0.86 |
chr5_142920434_142920596 | 22.84 |
Actb |
actin, beta |
13761 |
0.14 |
chr14_52103963_52104507 | 22.72 |
Hnrnpc |
heterogeneous nuclear ribonucleoprotein C |
207 |
0.88 |
chrX_20950586_20951120 | 22.62 |
Elk1 |
ELK1, member of ETS oncogene family |
245 |
0.87 |
chr5_103760139_103760316 | 22.53 |
Aff1 |
AF4/FMR2 family, member 1 |
5654 |
0.23 |
chr7_4752774_4753471 | 22.41 |
Cox6b2 |
cytochrome c oxidase subunit 6B2 |
28 |
0.93 |
chr8_83594390_83594775 | 22.37 |
Tecr |
trans-2,3-enoyl-CoA reductase |
95 |
0.93 |
chr7_142568972_142569582 | 22.35 |
H19 |
H19, imprinted maternally expressed transcript |
7261 |
0.1 |
chr2_25224548_25225074 | 22.31 |
Tubb4b |
tubulin, beta 4B class IVB |
109 |
0.87 |
chr2_172370522_172370713 | 22.25 |
Cstf1 |
cleavage stimulation factor, 3' pre-RNA, subunit 1 |
64 |
0.51 |
chr1_82836684_82836853 | 22.22 |
Gm22396 |
predicted gene, 22396 |
2678 |
0.14 |
chr11_75531471_75531831 | 22.11 |
Slc43a2 |
solute carrier family 43, member 2 |
43 |
0.93 |
chr5_117133502_117133674 | 22.11 |
Taok3 |
TAO kinase 3 |
0 |
0.97 |
chr9_21424295_21424999 | 21.82 |
Dnm2 |
dynamin 2 |
261 |
0.85 |
chr5_122821226_122821528 | 21.69 |
Anapc5 |
anaphase-promoting complex subunit 5 |
38 |
0.97 |
chr17_25015659_25016167 | 21.67 |
Cramp1l |
cramped chromatin regulator homolog 1 |
125 |
0.56 |
chr4_120825189_120825394 | 21.48 |
Nfyc |
nuclear transcription factor-Y gamma |
393 |
0.78 |
chr19_4811594_4811784 | 21.46 |
Rbm14 |
RNA binding motif protein 14 |
55 |
0.51 |
chr3_96269424_96270161 | 21.41 |
H2bc18 |
H2B clustered histone 18 |
40 |
0.47 |
chr11_43681649_43682033 | 21.40 |
Pwwp2a |
PWWP domain containing 2A |
157 |
0.95 |
chr10_122762843_122763007 | 21.40 |
A430028G04Rik |
RIKEN cDNA A430028G04 gene |
4515 |
0.18 |
chr5_137601005_137601275 | 21.34 |
Mospd3 |
motile sperm domain containing 3 |
82 |
0.81 |
chr4_134273428_134273760 | 21.34 |
Pdik1l |
PDLIM1 interacting kinase 1 like |
13631 |
0.08 |
chr12_111442215_111442766 | 21.32 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
21 |
0.96 |
chr2_79259164_79259332 | 21.26 |
Itga4 |
integrin alpha 4 |
3301 |
0.3 |
chrX_10714525_10715126 | 21.06 |
Mid1ip1 |
Mid1 interacting protein 1 (gastrulation specific G12-like (zebrafish)) |
188 |
0.93 |
chr8_69716427_69717227 | 21.06 |
Zfp869 |
zinc finger protein 869 |
3 |
0.97 |
chr12_105009915_105010683 | 21.00 |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
490 |
0.67 |
chr8_124019948_124020121 | 21.00 |
Taf5l |
TATA-box binding protein associated factor 5 like |
906 |
0.35 |
chr7_126502319_126502991 | 20.97 |
Atxn2l |
ataxin 2-like |
241 |
0.85 |
chr17_24469704_24470446 | 20.94 |
E4f1 |
E4F transcription factor 1 |
116 |
0.71 |
chr16_38089098_38089604 | 20.89 |
Gsk3b |
glycogen synthase kinase 3 beta |
350 |
0.9 |
chr19_3575723_3576237 | 20.86 |
Ppp6r3 |
protein phosphatase 6, regulatory subunit 3 |
231 |
0.92 |
chrX_20617562_20617859 | 20.82 |
Rbm10 |
RNA binding motif protein 10 |
73 |
0.51 |
chr7_30599774_30600342 | 20.80 |
Zbtb32 |
zinc finger and BTB domain containing 32 |
1149 |
0.2 |
chr5_130143914_130144290 | 20.80 |
Kctd7 |
potassium channel tetramerisation domain containing 7 |
759 |
0.51 |
chrX_20364057_20365089 | 20.80 |
Rp2 |
retinitis pigmentosa 2 homolog |
2 |
0.97 |
chr6_142387058_142387234 | 20.72 |
Recql |
RecQ protein-like |
59 |
0.51 |
chr7_3644850_3645303 | 20.66 |
Gm15927 |
predicted gene 15927 |
189 |
0.46 |
chr9_20651852_20652224 | 20.62 |
Pin1 |
protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1 |
57 |
0.95 |
chr11_103966284_103967090 | 20.52 |
Arf2 |
ADP-ribosylation factor 2 |
52 |
0.98 |
chr2_174347204_174348264 | 20.35 |
Gm20721 |
predicted gene, 20721 |
1022 |
0.44 |
chr18_76241493_76241710 | 20.31 |
Smad2 |
SMAD family member 2 |
21 |
0.98 |
chr12_111537480_111538246 | 20.26 |
Eif5 |
eukaryotic translation initiation factor 5 |
153 |
0.92 |
chr8_84901775_84902039 | 20.22 |
Klf1 |
Kruppel-like factor 1 (erythroid) |
21 |
0.93 |
chr16_91647606_91647943 | 20.19 |
Son |
Son DNA binding protein |
105 |
0.9 |
chrX_7574307_7574613 | 20.16 |
Flicr |
Foxp3 regulating long intergenic noncoding RNA |
32 |
0.65 |
chr15_76248251_76248477 | 20.15 |
Mir6953 |
microRNA 6953 |
173 |
0.62 |
chr14_74972805_74972992 | 20.14 |
Gm4278 |
predicted gene 4278 |
2188 |
0.3 |
chr7_127208891_127209523 | 20.12 |
Mylpf |
myosin light chain, phosphorylatable, fast skeletal muscle |
308 |
0.64 |
chr2_164822823_164823128 | 20.11 |
Zswim1 |
zinc finger SWIM-type containing 1 |
38 |
0.93 |
chr8_123318522_123318710 | 20.01 |
Fanca |
Fanconi anemia, complementation group A |
40 |
0.95 |
chr19_4559099_4559259 | 19.98 |
Pcx |
pyruvate carboxylase |
369 |
0.82 |
chr6_116286832_116287192 | 19.97 |
Zfand4 |
zinc finger, AN1-type domain 4 |
459 |
0.75 |
chr7_3665418_3665776 | 19.96 |
Leng1 |
leukocyte receptor cluster (LRC) member 1 |
243 |
0.67 |
chr11_87591342_87592719 | 19.88 |
Mtmr4 |
myotubularin related protein 4 |
132 |
0.94 |
chr3_95625186_95625509 | 19.86 |
Ensa |
endosulfine alpha |
321 |
0.78 |
chr3_130709622_130710062 | 19.78 |
Ostc |
oligosaccharyltransferase complex subunit (non-catalytic) |
398 |
0.77 |
chr2_132252313_132253101 | 19.78 |
Pcna |
proliferating cell nuclear antigen |
105 |
0.89 |
chr11_40755163_40755522 | 19.78 |
Ccng1 |
cyclin G1 |
31 |
0.98 |
chr11_95041294_95041633 | 19.75 |
Pdk2 |
pyruvate dehydrogenase kinase, isoenzyme 2 |
109 |
0.94 |
chr2_70998843_70999110 | 19.72 |
Mettl8 |
methyltransferase like 8 |
16792 |
0.22 |
chr4_58970722_58971018 | 19.71 |
Ptgr1 |
prostaglandin reductase 1 |
16249 |
0.12 |
chr8_111300149_111300519 | 19.71 |
Rfwd3 |
ring finger and WD repeat domain 3 |
112 |
0.95 |
chr19_60226558_60226823 | 19.71 |
Fam204a |
family with sequence similarity 204, member A |
4 |
0.85 |
chr1_153899721_153900057 | 19.70 |
Mir8114 |
microRNA 8114 |
37 |
0.46 |
chr5_146829663_146829834 | 19.67 |
Rpl21 |
ribosomal protein L21 |
3142 |
0.16 |
chr14_59440359_59441525 | 19.66 |
Cab39l |
calcium binding protein 39-like |
30 |
0.52 |
chr6_83831205_83832132 | 19.61 |
Paip2b |
poly(A) binding protein interacting protein 2B |
32 |
0.94 |
chr8_111573405_111573914 | 19.60 |
Znrf1 |
zinc and ring finger 1 |
11819 |
0.18 |
chr8_57511459_57512353 | 19.57 |
Hmgb2 |
high mobility group box 2 |
1 |
0.96 |
chr4_134506347_134506530 | 19.54 |
Aunip |
aurora kinase A and ninein interacting protein |
4561 |
0.12 |
chr2_32137748_32138307 | 19.54 |
Prrc2b |
proline-rich coiled-coil 2B |
13055 |
0.11 |
chr1_131527624_131527960 | 19.43 |
Fam72a |
family with sequence similarity 72, member A |
111 |
0.83 |
chr7_39552349_39552551 | 19.43 |
Gm37494 |
predicted gene, 37494 |
50 |
0.96 |
chr16_14317334_14317698 | 19.40 |
Fopnl |
Fgfr1op N-terminal like |
111 |
0.95 |
chr12_85824510_85824695 | 19.26 |
Erg28 |
ergosterol biosynthesis 28 |
52 |
0.5 |
chr10_24823379_24823540 | 19.23 |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
8347 |
0.2 |
chr2_118659939_118660226 | 19.19 |
Pak6 |
p21 (RAC1) activated kinase 6 |
3221 |
0.19 |
chr9_21220479_21220816 | 19.14 |
Gm16754 |
predicted gene, 16754 |
4724 |
0.1 |
chr5_142906232_142906895 | 19.14 |
Actb |
actin, beta |
109 |
0.96 |
chr3_89418219_89418613 | 19.11 |
Shc1 |
src homology 2 domain-containing transforming protein C1 |
27 |
0.49 |
chr6_113077152_113077563 | 19.11 |
Setd5 |
SET domain containing 5 |
8 |
0.5 |
chr1_189688064_189688766 | 19.10 |
Cenpf |
centromere protein F |
329 |
0.87 |
chr12_91849095_91849460 | 19.05 |
Sel1l |
sel-1 suppressor of lin-12-like (C. elegans) |
120 |
0.95 |
chr2_180119023_180119318 | 19.04 |
Osbpl2 |
oxysterol binding protein-like 2 |
136 |
0.93 |
chr8_88298055_88298249 | 19.03 |
Adcy7 |
adenylate cyclase 7 |
2227 |
0.3 |
chr4_134853186_134853558 | 18.97 |
Maco1 |
macoilin 1 |
27 |
0.97 |
chrX_93831605_93832731 | 18.90 |
Pdk3 |
pyruvate dehydrogenase kinase, isoenzyme 3 |
33 |
0.98 |
chr1_134060499_134061137 | 18.88 |
Btg2 |
BTG anti-proliferation factor 2 |
18302 |
0.12 |
chr9_107635430_107635650 | 18.84 |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
173 |
0.85 |
chr19_4793811_4794180 | 18.83 |
Rbm4 |
RNA binding motif protein 4 |
94 |
0.92 |
chr19_44283591_44284731 | 18.82 |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
9513 |
0.11 |
chr3_90475883_90476196 | 18.80 |
Ilf2 |
interleukin enhancer binding factor 2 |
87 |
0.92 |
chrX_7648550_7649417 | 18.79 |
Syp |
synaptophysin |
5074 |
0.08 |
chr15_80710968_80711303 | 18.69 |
Tnrc6b |
trinucleotide repeat containing 6b |
178 |
0.9 |
chr3_100488535_100489982 | 18.68 |
Tent5c |
terminal nucleotidyltransferase 5C |
60 |
0.85 |
chr9_64933958_64934353 | 18.67 |
Slc24a1 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 |
17452 |
0.13 |
chr5_122501856_122502977 | 18.64 |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
191 |
0.88 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
20.6 | 61.8 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
18.4 | 73.5 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
14.6 | 43.9 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
13.2 | 52.8 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
13.2 | 39.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
12.7 | 38.2 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
12.2 | 48.7 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
11.5 | 34.6 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
10.9 | 43.7 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
10.7 | 32.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
10.5 | 62.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
10.4 | 31.1 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
10.1 | 50.4 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
9.7 | 29.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
9.4 | 37.7 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
9.1 | 45.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
8.8 | 26.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
8.3 | 25.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
8.2 | 8.2 | GO:0016458 | gene silencing(GO:0016458) |
8.2 | 24.5 | GO:0031627 | telomeric loop formation(GO:0031627) |
8.0 | 24.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
8.0 | 24.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
8.0 | 23.9 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
8.0 | 31.9 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
7.9 | 23.8 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
7.8 | 23.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
7.5 | 22.5 | GO:0000087 | mitotic M phase(GO:0000087) |
7.5 | 37.5 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
7.5 | 22.5 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
7.3 | 21.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
7.3 | 21.9 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
7.2 | 21.6 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
6.8 | 20.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
6.7 | 20.1 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
6.7 | 20.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
6.6 | 26.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
6.5 | 12.9 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
6.2 | 12.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
6.2 | 18.7 | GO:0040031 | snRNA modification(GO:0040031) |
6.1 | 24.6 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
6.1 | 24.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
6.0 | 18.1 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
6.0 | 18.1 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
6.0 | 36.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
6.0 | 24.0 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
6.0 | 11.9 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
6.0 | 65.6 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
5.9 | 29.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
5.9 | 17.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
5.9 | 29.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
5.8 | 162.5 | GO:0048821 | erythrocyte development(GO:0048821) |
5.8 | 17.4 | GO:0019086 | late viral transcription(GO:0019086) |
5.8 | 23.1 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
5.8 | 5.8 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
5.7 | 51.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
5.7 | 28.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
5.5 | 16.6 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
5.5 | 16.4 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
5.5 | 16.4 | GO:0070836 | caveola assembly(GO:0070836) |
5.4 | 21.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
5.4 | 27.0 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
5.4 | 37.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
5.4 | 10.7 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
5.3 | 21.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
5.3 | 21.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
5.3 | 21.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
5.3 | 21.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
5.3 | 10.6 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
5.3 | 42.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
5.2 | 15.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
5.2 | 15.7 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
5.2 | 20.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
5.2 | 10.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
5.2 | 25.8 | GO:0051255 | mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
5.1 | 15.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
5.1 | 20.5 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
5.0 | 14.9 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
5.0 | 14.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
4.9 | 34.2 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
4.9 | 9.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
4.9 | 24.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
4.9 | 38.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
4.8 | 62.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
4.8 | 14.4 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
4.7 | 9.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
4.7 | 19.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
4.7 | 28.4 | GO:0048102 | autophagic cell death(GO:0048102) |
4.7 | 14.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
4.7 | 9.3 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
4.6 | 13.9 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
4.6 | 18.5 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
4.6 | 13.8 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
4.5 | 18.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
4.5 | 13.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
4.5 | 45.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
4.5 | 13.5 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
4.5 | 26.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
4.4 | 26.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
4.4 | 13.3 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
4.4 | 4.4 | GO:0051231 | spindle elongation(GO:0051231) |
4.4 | 13.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
4.4 | 4.4 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
4.4 | 8.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
4.4 | 21.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
4.3 | 65.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
4.3 | 17.3 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
4.3 | 12.9 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
4.3 | 12.9 | GO:0050904 | diapedesis(GO:0050904) |
4.3 | 46.9 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
4.2 | 16.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
4.2 | 20.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
4.1 | 20.7 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
4.1 | 28.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
4.1 | 12.3 | GO:2000562 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
4.1 | 20.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
4.0 | 28.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
4.0 | 12.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
4.0 | 12.1 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) |
4.0 | 24.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
4.0 | 4.0 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
4.0 | 8.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
4.0 | 63.7 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
4.0 | 27.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
4.0 | 11.9 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
3.9 | 15.6 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
3.9 | 7.8 | GO:0030242 | pexophagy(GO:0030242) |
3.9 | 11.6 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
3.8 | 49.7 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
3.8 | 7.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
3.8 | 11.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
3.8 | 53.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
3.8 | 15.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
3.7 | 11.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
3.7 | 11.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
3.7 | 11.1 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
3.7 | 3.7 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
3.7 | 11.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
3.7 | 14.6 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
3.6 | 18.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
3.6 | 10.9 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
3.6 | 3.6 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
3.6 | 10.8 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
3.6 | 14.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
3.6 | 42.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
3.6 | 14.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
3.5 | 46.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
3.5 | 17.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
3.5 | 10.6 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
3.5 | 14.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
3.5 | 6.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.4 | 20.6 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
3.4 | 34.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
3.4 | 10.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
3.4 | 10.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
3.4 | 17.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
3.4 | 40.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
3.4 | 13.5 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
3.4 | 10.1 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
3.3 | 10.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
3.3 | 16.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
3.3 | 9.9 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
3.3 | 6.6 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
3.3 | 6.6 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
3.3 | 3.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
3.3 | 6.5 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
3.2 | 13.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
3.2 | 64.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
3.2 | 19.4 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
3.2 | 12.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
3.2 | 16.1 | GO:0001842 | neural fold formation(GO:0001842) |
3.2 | 6.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
3.2 | 6.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
3.2 | 22.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
3.2 | 6.4 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
3.2 | 9.5 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
3.2 | 9.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
3.2 | 12.7 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
3.2 | 22.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
3.2 | 12.7 | GO:0006551 | leucine metabolic process(GO:0006551) |
3.1 | 34.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
3.1 | 6.3 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
3.1 | 40.8 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
3.1 | 15.6 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
3.1 | 9.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
3.1 | 9.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
3.1 | 3.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
3.1 | 3.1 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
3.1 | 12.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
3.1 | 3.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
3.1 | 9.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
3.1 | 9.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
3.1 | 18.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
3.1 | 12.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
3.1 | 9.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
3.1 | 6.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
3.0 | 12.2 | GO:0097460 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
3.0 | 18.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
3.0 | 12.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
3.0 | 9.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
3.0 | 9.1 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
3.0 | 9.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
3.0 | 6.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
3.0 | 9.0 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
3.0 | 6.0 | GO:0015755 | fructose transport(GO:0015755) |
3.0 | 8.9 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
3.0 | 5.9 | GO:0002432 | granuloma formation(GO:0002432) |
3.0 | 11.8 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
3.0 | 17.7 | GO:0051013 | microtubule severing(GO:0051013) |
2.9 | 8.8 | GO:0046104 | thymidine metabolic process(GO:0046104) |
2.9 | 8.8 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
2.9 | 26.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
2.9 | 8.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
2.9 | 14.5 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
2.9 | 8.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.9 | 25.8 | GO:0016556 | mRNA modification(GO:0016556) |
2.9 | 11.5 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
2.8 | 5.7 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
2.8 | 5.7 | GO:0034214 | protein hexamerization(GO:0034214) |
2.8 | 11.4 | GO:0019230 | proprioception(GO:0019230) |
2.8 | 14.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
2.8 | 2.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.8 | 11.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
2.8 | 16.9 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
2.8 | 2.8 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
2.8 | 30.7 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
2.8 | 25.1 | GO:0031269 | pseudopodium assembly(GO:0031269) |
2.8 | 33.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
2.8 | 8.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
2.8 | 8.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
2.7 | 2.7 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
2.7 | 11.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
2.7 | 5.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
2.7 | 19.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
2.7 | 8.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
2.7 | 29.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
2.7 | 2.7 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
2.7 | 8.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.7 | 8.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.7 | 21.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
2.7 | 16.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
2.7 | 10.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
2.7 | 117.4 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
2.7 | 10.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
2.7 | 21.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
2.6 | 10.6 | GO:0015886 | heme transport(GO:0015886) |
2.6 | 7.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
2.6 | 28.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
2.5 | 5.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
2.5 | 7.6 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
2.5 | 7.6 | GO:1903232 | melanosome assembly(GO:1903232) |
2.5 | 10.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
2.5 | 15.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
2.5 | 7.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
2.5 | 54.9 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
2.5 | 14.9 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
2.5 | 14.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
2.5 | 19.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
2.5 | 14.8 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
2.5 | 9.8 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
2.4 | 2.4 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
2.4 | 7.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.4 | 2.4 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
2.4 | 9.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
2.4 | 12.0 | GO:0009642 | response to light intensity(GO:0009642) |
2.4 | 14.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
2.4 | 7.2 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
2.4 | 11.9 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
2.4 | 9.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
2.4 | 7.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.4 | 47.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
2.4 | 14.3 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
2.4 | 14.2 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
2.4 | 18.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
2.4 | 16.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
2.4 | 14.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
2.4 | 7.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
2.4 | 7.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
2.4 | 16.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
2.4 | 16.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
2.4 | 7.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
2.3 | 6.9 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
2.3 | 4.6 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
2.3 | 13.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
2.3 | 6.9 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
2.3 | 4.6 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
2.3 | 16.1 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
2.3 | 4.6 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
2.3 | 4.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
2.3 | 9.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
2.3 | 13.7 | GO:0034063 | stress granule assembly(GO:0034063) |
2.3 | 16.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
2.3 | 6.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
2.3 | 2.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
2.3 | 6.8 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
2.3 | 6.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.3 | 2.3 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
2.3 | 6.8 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
2.2 | 24.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
2.2 | 11.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
2.2 | 4.5 | GO:0009838 | abscission(GO:0009838) |
2.2 | 15.6 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
2.2 | 6.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
2.2 | 2.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
2.2 | 22.1 | GO:0034033 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
2.2 | 6.6 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
2.2 | 4.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.2 | 8.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
2.2 | 6.5 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
2.2 | 6.5 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
2.1 | 10.7 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
2.1 | 27.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
2.1 | 2.1 | GO:0010039 | response to iron ion(GO:0010039) |
2.1 | 23.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
2.1 | 6.4 | GO:0021747 | cochlear nucleus development(GO:0021747) |
2.1 | 8.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
2.1 | 4.3 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
2.1 | 10.6 | GO:0051225 | spindle assembly(GO:0051225) |
2.1 | 29.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
2.1 | 8.5 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
2.1 | 2.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
2.1 | 27.5 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
2.1 | 12.6 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
2.1 | 10.5 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
2.1 | 6.3 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
2.1 | 14.7 | GO:0007097 | nuclear migration(GO:0007097) |
2.1 | 10.5 | GO:0006547 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
2.1 | 6.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
2.1 | 2.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
2.1 | 22.9 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
2.1 | 12.5 | GO:0016266 | O-glycan processing(GO:0016266) |
2.1 | 10.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
2.1 | 12.4 | GO:0043486 | histone exchange(GO:0043486) |
2.1 | 10.3 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
2.0 | 24.6 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
2.0 | 6.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.0 | 4.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
2.0 | 6.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
2.0 | 4.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
2.0 | 40.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
2.0 | 12.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
2.0 | 16.1 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
2.0 | 20.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
2.0 | 8.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
2.0 | 14.1 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
2.0 | 6.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
2.0 | 12.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
2.0 | 6.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
2.0 | 8.0 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
2.0 | 2.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
2.0 | 4.0 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
2.0 | 5.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
2.0 | 7.8 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
2.0 | 37.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.0 | 9.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
2.0 | 17.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
2.0 | 5.9 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.9 | 1.9 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.9 | 3.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.9 | 7.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
1.9 | 15.5 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
1.9 | 5.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.9 | 9.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.9 | 5.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.9 | 3.8 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
1.9 | 1.9 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.9 | 36.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
1.9 | 19.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
1.9 | 1.9 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.9 | 11.4 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
1.9 | 7.6 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
1.9 | 3.8 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.9 | 3.8 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
1.9 | 1.9 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
1.9 | 1.9 | GO:0006573 | valine metabolic process(GO:0006573) |
1.9 | 5.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.9 | 7.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.9 | 1.9 | GO:0015744 | succinate transport(GO:0015744) |
1.9 | 9.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.9 | 11.3 | GO:0006265 | DNA topological change(GO:0006265) |
1.9 | 9.3 | GO:0033227 | dsRNA transport(GO:0033227) |
1.9 | 28.0 | GO:0072520 | seminiferous tubule development(GO:0072520) |
1.9 | 7.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.9 | 1.9 | GO:0048242 | epinephrine secretion(GO:0048242) |
1.8 | 3.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
1.8 | 1.8 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.8 | 5.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.8 | 5.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.8 | 3.7 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.8 | 9.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.8 | 5.5 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
1.8 | 5.5 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
1.8 | 1.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
1.8 | 12.7 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
1.8 | 3.6 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
1.8 | 5.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.8 | 1.8 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.8 | 12.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
1.8 | 1.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
1.8 | 21.5 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
1.8 | 3.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.8 | 8.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.8 | 7.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.8 | 8.9 | GO:0033504 | floor plate development(GO:0033504) |
1.8 | 3.5 | GO:0033572 | transferrin transport(GO:0033572) |
1.8 | 10.6 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
1.8 | 3.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.8 | 7.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.8 | 7.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.8 | 1.8 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
1.8 | 15.8 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
1.8 | 5.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.8 | 7.0 | GO:1901660 | calcium ion export(GO:1901660) |
1.8 | 21.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
1.7 | 3.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.7 | 17.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
1.7 | 5.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.7 | 3.4 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
1.7 | 10.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
1.7 | 5.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
1.7 | 6.8 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
1.7 | 5.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
1.7 | 45.9 | GO:0051310 | metaphase plate congression(GO:0051310) |
1.7 | 10.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
1.7 | 5.1 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
1.7 | 8.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
1.7 | 5.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.7 | 3.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.7 | 6.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.7 | 5.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.7 | 11.8 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
1.7 | 10.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.7 | 3.3 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.7 | 3.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.7 | 10.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
1.7 | 13.3 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
1.7 | 1.7 | GO:0006382 | adenosine to inosine editing(GO:0006382) base conversion or substitution editing(GO:0016553) |
1.7 | 3.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.7 | 6.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
1.7 | 8.3 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
1.6 | 9.9 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.6 | 8.2 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.6 | 6.6 | GO:0007296 | vitellogenesis(GO:0007296) |
1.6 | 1.6 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.6 | 4.9 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
1.6 | 16.3 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
1.6 | 4.9 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
1.6 | 3.3 | GO:0072718 | response to cisplatin(GO:0072718) |
1.6 | 11.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
1.6 | 1.6 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.6 | 14.6 | GO:0051782 | negative regulation of cell division(GO:0051782) |
1.6 | 1.6 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
1.6 | 6.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.6 | 3.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
1.6 | 9.6 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.6 | 14.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.6 | 1.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.6 | 1.6 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
1.6 | 6.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.6 | 14.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
1.6 | 3.1 | GO:0008228 | opsonization(GO:0008228) |
1.6 | 7.9 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
1.6 | 1.6 | GO:0072553 | terminal button organization(GO:0072553) |
1.6 | 4.7 | GO:0051409 | response to nitrosative stress(GO:0051409) |
1.6 | 7.9 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
1.6 | 7.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.6 | 6.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.6 | 9.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.5 | 7.7 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.5 | 7.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.5 | 12.3 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.5 | 3.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.5 | 7.7 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
1.5 | 15.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
1.5 | 22.9 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
1.5 | 13.7 | GO:0006907 | pinocytosis(GO:0006907) |
1.5 | 15.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
1.5 | 13.7 | GO:0016926 | protein desumoylation(GO:0016926) |
1.5 | 13.7 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
1.5 | 15.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
1.5 | 15.2 | GO:0006298 | mismatch repair(GO:0006298) |
1.5 | 4.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.5 | 7.6 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
1.5 | 3.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.5 | 3.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.5 | 6.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.5 | 4.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.5 | 6.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.5 | 1.5 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
1.5 | 5.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.5 | 4.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.5 | 16.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
1.5 | 3.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
1.5 | 3.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.5 | 4.4 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
1.5 | 2.9 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
1.5 | 49.9 | GO:0006639 | acylglycerol metabolic process(GO:0006639) |
1.5 | 2.9 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
1.5 | 4.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.5 | 5.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.5 | 1.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.5 | 10.2 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
1.5 | 17.4 | GO:0045116 | protein neddylation(GO:0045116) |
1.5 | 4.4 | GO:0035482 | gastric motility(GO:0035482) |
1.4 | 85.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
1.4 | 8.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.4 | 28.8 | GO:0016180 | snRNA processing(GO:0016180) |
1.4 | 2.9 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
1.4 | 169.0 | GO:0007059 | chromosome segregation(GO:0007059) |
1.4 | 20.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
1.4 | 1.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.4 | 5.7 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
1.4 | 39.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
1.4 | 12.6 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.4 | 4.2 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
1.4 | 4.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.4 | 84.8 | GO:0051028 | mRNA transport(GO:0051028) |
1.4 | 18.0 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
1.4 | 4.1 | GO:0006108 | malate metabolic process(GO:0006108) |
1.4 | 4.1 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.4 | 9.6 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.4 | 2.7 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
1.4 | 5.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.4 | 4.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.4 | 5.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.4 | 2.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.4 | 6.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.4 | 39.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.4 | 8.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
1.4 | 2.7 | GO:0002254 | kinin cascade(GO:0002254) |
1.3 | 6.7 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.3 | 8.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.3 | 5.4 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
1.3 | 13.4 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
1.3 | 1.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.3 | 8.0 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
1.3 | 41.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
1.3 | 46.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
1.3 | 6.6 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
1.3 | 1.3 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
1.3 | 2.6 | GO:0019081 | viral translation(GO:0019081) |
1.3 | 2.6 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.3 | 15.7 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
1.3 | 45.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
1.3 | 23.5 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
1.3 | 3.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
1.3 | 10.4 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
1.3 | 5.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.3 | 27.2 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
1.3 | 3.9 | GO:0015888 | thiamine transport(GO:0015888) |
1.3 | 9.0 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
1.3 | 5.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.3 | 3.9 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.3 | 6.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.3 | 9.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
1.3 | 8.9 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.3 | 5.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.3 | 54.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
1.3 | 5.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.3 | 2.5 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
1.3 | 1.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
1.2 | 7.5 | GO:0006477 | protein sulfation(GO:0006477) |
1.2 | 8.7 | GO:0015825 | L-serine transport(GO:0015825) |
1.2 | 1.2 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
1.2 | 4.9 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.2 | 3.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
1.2 | 11.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.2 | 23.4 | GO:0042073 | intraciliary transport(GO:0042073) |
1.2 | 13.6 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
1.2 | 2.5 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
1.2 | 1.2 | GO:1902566 | regulation of eosinophil degranulation(GO:0043309) regulation of eosinophil activation(GO:1902566) |
1.2 | 7.4 | GO:0043248 | proteasome assembly(GO:0043248) |
1.2 | 4.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.2 | 4.9 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.2 | 2.4 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.2 | 1.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.2 | 4.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
1.2 | 1.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.2 | 4.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.2 | 1.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.2 | 8.4 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
1.2 | 1.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
1.2 | 3.6 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.2 | 4.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.2 | 19.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
1.2 | 3.6 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
1.2 | 14.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
1.2 | 3.6 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.2 | 2.4 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.2 | 38.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
1.2 | 8.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.2 | 16.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.2 | 46.5 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
1.2 | 2.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.2 | 7.0 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
1.2 | 2.3 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
1.2 | 1.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.2 | 4.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.1 | 3.4 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
1.1 | 1.1 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
1.1 | 3.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.1 | 3.4 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
1.1 | 13.7 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
1.1 | 3.4 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
1.1 | 10.3 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
1.1 | 29.7 | GO:0000910 | cytokinesis(GO:0000910) |
1.1 | 6.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.1 | 6.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
1.1 | 6.8 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
1.1 | 1.1 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
1.1 | 5.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.1 | 3.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.1 | 3.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.1 | 7.9 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
1.1 | 2.2 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.1 | 2.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
1.1 | 15.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
1.1 | 19.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.1 | 5.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
1.1 | 5.6 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
1.1 | 4.4 | GO:0015808 | L-alanine transport(GO:0015808) |
1.1 | 4.4 | GO:0046415 | urate metabolic process(GO:0046415) |
1.1 | 3.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.1 | 8.8 | GO:0097286 | iron ion import(GO:0097286) |
1.1 | 20.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.1 | 1.1 | GO:0019627 | urea metabolic process(GO:0019627) |
1.1 | 1.1 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.1 | 1.1 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
1.1 | 3.3 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
1.1 | 2.2 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
1.1 | 2.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.1 | 7.6 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
1.1 | 4.3 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
1.1 | 5.4 | GO:0017085 | response to insecticide(GO:0017085) |
1.1 | 1.1 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
1.1 | 2.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
1.1 | 5.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.1 | 13.8 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
1.1 | 3.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.1 | 2.1 | GO:0090224 | regulation of spindle organization(GO:0090224) |
1.1 | 1.1 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
1.1 | 3.2 | GO:0015871 | choline transport(GO:0015871) |
1.1 | 2.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.0 | 46.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
1.0 | 1.0 | GO:0071548 | response to dexamethasone(GO:0071548) |
1.0 | 11.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
1.0 | 3.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
1.0 | 3.1 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
1.0 | 7.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
1.0 | 1.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.0 | 5.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
1.0 | 30.9 | GO:0009060 | aerobic respiration(GO:0009060) |
1.0 | 1.0 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.0 | 3.1 | GO:0016264 | gap junction assembly(GO:0016264) |
1.0 | 7.1 | GO:0007379 | segment specification(GO:0007379) |
1.0 | 5.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.0 | 2.0 | GO:0015819 | lysine transport(GO:0015819) |
1.0 | 31.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
1.0 | 14.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
1.0 | 32.5 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
1.0 | 2.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.0 | 8.1 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
1.0 | 10.1 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
1.0 | 3.0 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.0 | 2.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.0 | 6.0 | GO:0051639 | actin filament network formation(GO:0051639) |
1.0 | 6.0 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
1.0 | 17.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
1.0 | 5.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.0 | 2.0 | GO:0072611 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
1.0 | 3.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.0 | 4.9 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
1.0 | 3.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.0 | 3.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.0 | 1.0 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
1.0 | 10.8 | GO:0000154 | rRNA modification(GO:0000154) |
1.0 | 18.6 | GO:0048240 | sperm capacitation(GO:0048240) |
1.0 | 11.7 | GO:0051601 | exocyst localization(GO:0051601) |
1.0 | 2.9 | GO:0018101 | protein citrullination(GO:0018101) |
1.0 | 22.4 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
1.0 | 12.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.0 | 1.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
1.0 | 13.6 | GO:0071320 | cellular response to cAMP(GO:0071320) |
1.0 | 1.9 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
1.0 | 1.0 | GO:0001302 | replicative cell aging(GO:0001302) |
1.0 | 7.7 | GO:0034331 | cell junction maintenance(GO:0034331) |
1.0 | 1.9 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
1.0 | 3.9 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
1.0 | 10.6 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
1.0 | 23.0 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
1.0 | 1.0 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
1.0 | 8.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
1.0 | 4.8 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
1.0 | 1.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
1.0 | 6.7 | GO:0007143 | female meiotic division(GO:0007143) |
0.9 | 1.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.9 | 3.8 | GO:0042168 | heme metabolic process(GO:0042168) |
0.9 | 0.9 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
0.9 | 0.9 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.9 | 79.5 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.9 | 4.7 | GO:0002934 | desmosome organization(GO:0002934) |
0.9 | 2.8 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.9 | 1.9 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.9 | 0.9 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.9 | 3.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.9 | 7.4 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.9 | 12.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.9 | 2.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.9 | 2.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.9 | 2.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.9 | 0.9 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.9 | 13.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.9 | 9.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.9 | 6.3 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.9 | 9.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.9 | 8.0 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.9 | 2.7 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
0.9 | 38.9 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.9 | 5.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.9 | 36.7 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.9 | 5.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.9 | 2.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.9 | 2.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.9 | 1.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.9 | 0.9 | GO:0051188 | cofactor biosynthetic process(GO:0051188) |
0.9 | 5.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.9 | 2.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.9 | 2.6 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.9 | 0.9 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.9 | 20.7 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.9 | 8.6 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.9 | 1.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.9 | 8.5 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.9 | 1.7 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.8 | 0.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.8 | 2.5 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.8 | 2.5 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.8 | 9.9 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.8 | 2.5 | GO:0015867 | ATP transport(GO:0015867) |
0.8 | 0.8 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.8 | 0.8 | GO:0043090 | amino acid import(GO:0043090) |
0.8 | 2.5 | GO:0051775 | response to redox state(GO:0051775) |
0.8 | 3.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.8 | 13.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.8 | 0.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.8 | 1.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.8 | 5.7 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.8 | 2.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.8 | 0.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.8 | 0.8 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.8 | 0.8 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.8 | 3.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.8 | 3.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.8 | 1.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.8 | 2.4 | GO:0016559 | peroxisome fission(GO:0016559) |
0.8 | 0.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.8 | 11.2 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.8 | 17.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.8 | 1.6 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.8 | 0.8 | GO:0032509 | regulation of multivesicular body size(GO:0010796) endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.8 | 6.3 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.8 | 3.2 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.8 | 2.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.8 | 10.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.8 | 6.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.8 | 7.8 | GO:0007602 | phototransduction(GO:0007602) |
0.8 | 79.6 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.8 | 0.8 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.8 | 6.9 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.8 | 4.6 | GO:0001556 | oocyte maturation(GO:0001556) |
0.8 | 2.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.8 | 0.8 | GO:0010520 | meiotic gene conversion(GO:0006311) regulation of reciprocal meiotic recombination(GO:0010520) gene conversion(GO:0035822) |
0.8 | 3.8 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.8 | 0.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.8 | 1.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.8 | 1.5 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.8 | 6.8 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.8 | 30.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.8 | 0.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.8 | 3.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.8 | 5.3 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.7 | 0.7 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.7 | 8.9 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.7 | 5.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.7 | 1.5 | GO:0035927 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.7 | 8.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.7 | 16.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.7 | 5.9 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.7 | 0.7 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.7 | 3.7 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.7 | 6.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.7 | 20.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.7 | 0.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.7 | 0.7 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.7 | 15.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.7 | 2.9 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.7 | 0.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.7 | 14.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.7 | 2.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.7 | 2.9 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.7 | 2.9 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.7 | 2.9 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.7 | 8.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.7 | 0.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.7 | 22.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.7 | 1.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.7 | 1.4 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.7 | 0.7 | GO:0070555 | response to interleukin-1(GO:0070555) |
0.7 | 0.7 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.7 | 3.5 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.7 | 1.4 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.7 | 1.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.7 | 0.7 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.7 | 2.1 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.7 | 2.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.7 | 6.8 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.7 | 4.1 | GO:0007127 | meiosis I(GO:0007127) |
0.7 | 4.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.7 | 0.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.7 | 2.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.7 | 2.0 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.7 | 2.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.7 | 0.7 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.7 | 0.7 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.7 | 10.6 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.7 | 21.8 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.7 | 43.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.7 | 10.5 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.7 | 3.3 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.7 | 8.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.7 | 3.3 | GO:0060426 | lung vasculature development(GO:0060426) |
0.7 | 7.2 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.6 | 1.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.6 | 1.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.6 | 1.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.6 | 4.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.6 | 6.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.6 | 10.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.6 | 3.2 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.6 | 1.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.6 | 4.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.6 | 10.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.6 | 8.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.6 | 2.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.6 | 15.7 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.6 | 6.9 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.6 | 1.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.6 | 3.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.6 | 29.0 | GO:0006457 | protein folding(GO:0006457) |
0.6 | 1.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.6 | 1.2 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.6 | 0.6 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.6 | 0.6 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.6 | 2.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.6 | 0.6 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.6 | 0.6 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.6 | 3.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.6 | 4.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.6 | 1.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.6 | 1.2 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.6 | 4.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.6 | 1.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.6 | 0.6 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.6 | 1.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.6 | 1.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.6 | 4.8 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.6 | 1.2 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) |
0.6 | 4.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.6 | 1.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.6 | 0.6 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.6 | 1.8 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.6 | 0.6 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.6 | 5.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.6 | 11.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.6 | 4.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.6 | 1.7 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.6 | 3.5 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.6 | 2.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.6 | 5.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.6 | 1.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 0.6 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.6 | 0.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.6 | 4.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.6 | 0.6 | GO:0060157 | urinary bladder development(GO:0060157) |
0.6 | 3.4 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.6 | 4.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.6 | 2.3 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.6 | 1.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.6 | 1.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.6 | 2.8 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.6 | 0.6 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.6 | 18.5 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.6 | 2.8 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.6 | 0.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.6 | 3.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.6 | 7.8 | GO:0015893 | drug transport(GO:0015893) |
0.6 | 1.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.6 | 1.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.6 | 1.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.6 | 1.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.6 | 1.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.6 | 1.7 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.6 | 2.2 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.6 | 75.0 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.6 | 2.8 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.6 | 0.6 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
0.5 | 3.3 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.5 | 9.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.5 | 2.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.5 | 1.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.5 | 4.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.5 | 4.9 | GO:0006301 | postreplication repair(GO:0006301) |
0.5 | 0.5 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.5 | 1.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 0.5 | GO:0006809 | nitric oxide biosynthetic process(GO:0006809) |
0.5 | 1.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.5 | 1.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.5 | 1.6 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.5 | 4.8 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.5 | 0.5 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.5 | 4.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.5 | 1.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 5.3 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.5 | 0.5 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.5 | 1.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 2.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.5 | 0.5 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.5 | 15.7 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.5 | 2.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.5 | 0.5 | GO:0060416 | response to growth hormone(GO:0060416) |
0.5 | 1.6 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.5 | 2.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.5 | 145.6 | GO:0006396 | RNA processing(GO:0006396) |
0.5 | 2.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.5 | 17.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.5 | 15.9 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.5 | 1.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.5 | 3.6 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.5 | 8.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.5 | 6.5 | GO:0036503 | ERAD pathway(GO:0036503) |
0.5 | 1.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 0.5 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.5 | 10.9 | GO:0048286 | lung alveolus development(GO:0048286) |
0.5 | 3.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.5 | 1.0 | GO:0015809 | arginine transport(GO:0015809) |
0.5 | 0.5 | GO:0070986 | left/right axis specification(GO:0070986) |
0.5 | 11.8 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.5 | 1.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.5 | 6.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.5 | 0.5 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.5 | 1.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.5 | 5.8 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.5 | 1.0 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.5 | 1.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 3.8 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.5 | 0.5 | GO:0061511 | centriole elongation(GO:0061511) |
0.5 | 0.5 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.5 | 2.3 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.5 | 0.5 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.5 | 12.9 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.5 | 0.5 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.5 | 5.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.5 | 9.7 | GO:0007030 | Golgi organization(GO:0007030) |
0.5 | 0.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.5 | 2.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.5 | 3.2 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.5 | 2.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.5 | 0.5 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.5 | 3.2 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.5 | 0.9 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.5 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 2.7 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.4 | 0.9 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.4 | 0.9 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.4 | 3.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.4 | 11.0 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.4 | 0.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 0.4 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.4 | 0.4 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.4 | 3.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 0.9 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.4 | 2.1 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.4 | 0.4 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.4 | 1.3 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.4 | 0.8 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.4 | 0.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.4 | 3.7 | GO:0045851 | pH reduction(GO:0045851) |
0.4 | 1.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 2.5 | GO:0046688 | response to copper ion(GO:0046688) |
0.4 | 2.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 37.9 | GO:0032259 | methylation(GO:0032259) |
0.4 | 1.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 1.2 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.4 | 5.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.4 | 0.4 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.4 | 1.6 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.4 | 0.4 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.4 | 1.2 | GO:0072666 | protein targeting to vacuole(GO:0006623) establishment of protein localization to vacuole(GO:0072666) |
0.4 | 2.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.4 | 3.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 10.0 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.4 | 0.8 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.4 | 0.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 0.4 | GO:0032094 | response to food(GO:0032094) |
0.4 | 2.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.4 | 1.2 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.4 | 0.4 | GO:0006833 | water transport(GO:0006833) |
0.4 | 0.8 | GO:0051973 | regulation of telomerase activity(GO:0051972) positive regulation of telomerase activity(GO:0051973) |
0.4 | 7.4 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.4 | 2.7 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.4 | 0.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.4 | 7.8 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.4 | 3.9 | GO:0071467 | cellular response to pH(GO:0071467) |
0.4 | 0.4 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.4 | 5.0 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.4 | 0.8 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.4 | 3.0 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.4 | 0.8 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.4 | 1.9 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.4 | 1.1 | GO:0009063 | cellular amino acid catabolic process(GO:0009063) |
0.4 | 1.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.4 | 2.6 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.4 | 3.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.4 | 1.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.4 | 0.4 | GO:1901018 | positive regulation of potassium ion transmembrane transporter activity(GO:1901018) |
0.4 | 2.6 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.4 | 3.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.4 | 0.4 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.4 | 6.5 | GO:0042278 | purine nucleoside metabolic process(GO:0042278) |
0.4 | 0.4 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.4 | 1.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.4 | 2.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.4 | 0.4 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.4 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 1.1 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.4 | 4.2 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.4 | 1.4 | GO:0031929 | TOR signaling(GO:0031929) |
0.3 | 1.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 1.7 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.3 | 0.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.3 | 0.3 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.3 | 0.3 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.3 | 3.8 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.3 | 0.7 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 0.7 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.3 | 1.3 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.3 | 1.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.3 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.7 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 0.3 | GO:0015791 | polyol transport(GO:0015791) |
0.3 | 0.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 0.7 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.3 | 1.3 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 0.7 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.3 | 1.3 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.3 | 0.3 | GO:2000394 | regulation of lamellipodium morphogenesis(GO:2000392) positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.3 | 1.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 0.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 2.3 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.3 | 0.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.3 | 2.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.3 | 0.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 11.1 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.3 | 1.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 0.3 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.3 | 0.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.3 | GO:0036315 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.3 | 52.6 | GO:0016311 | dephosphorylation(GO:0016311) |
0.3 | 1.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 0.3 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.3 | 1.3 | GO:0031103 | axon regeneration(GO:0031103) |
0.3 | 0.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 0.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 25.9 | GO:0016568 | chromatin modification(GO:0016568) |
0.3 | 0.9 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.3 | 0.3 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.3 | 3.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.3 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 0.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.3 | 1.8 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.3 | 0.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 1.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.3 | 0.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.3 | 1.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.9 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.3 | 4.2 | GO:0045453 | bone resorption(GO:0045453) |
0.3 | 3.6 | GO:0009408 | response to heat(GO:0009408) |
0.3 | 2.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.3 | 0.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.3 | 2.6 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.3 | 0.3 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 0.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 0.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.3 | 7.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 0.3 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.3 | 1.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.3 | 3.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 1.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.3 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.3 | 0.3 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.3 | 4.2 | GO:0007584 | response to nutrient(GO:0007584) |
0.3 | 1.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 0.3 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.3 | 0.6 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.3 | 2.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.3 | 1.3 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.3 | 1.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.3 | 0.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 0.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 0.5 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.3 | 0.5 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.3 | 0.5 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.3 | 0.3 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.3 | 0.3 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.3 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 0.3 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.3 | 0.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.2 | 0.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.5 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.2 | 4.2 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.2 | 3.0 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 1.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.2 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 0.7 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.2 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 3.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.5 | GO:0033865 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.2 | 3.2 | GO:0048477 | oogenesis(GO:0048477) |
0.2 | 2.3 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.2 | 0.2 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.2 | 1.2 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 0.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.2 | 0.5 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.2 | 0.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.2 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
0.2 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 2.0 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.2 | 0.5 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 1.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 1.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.2 | 0.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.7 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.2 | 11.2 | GO:0007286 | spermatid development(GO:0007286) |
0.2 | 1.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.2 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.2 | 1.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 23.1 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.2 | 0.2 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.2 | 0.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.2 | 0.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 0.9 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 1.7 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.2 | 0.2 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.2 | 0.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 1.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.2 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.2 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.2 | 0.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.2 | 0.6 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.2 | 0.2 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.2 | 1.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 0.4 | GO:0043954 | cellular component maintenance(GO:0043954) |
0.2 | 0.4 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.2 | 0.8 | GO:0072527 | pyrimidine-containing compound metabolic process(GO:0072527) |
0.2 | 0.4 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.2 | 0.6 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 0.6 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.2 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.8 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.2 | 0.8 | GO:0006497 | protein lipidation(GO:0006497) |
0.2 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.6 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 0.8 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.2 | 1.7 | GO:0030431 | sleep(GO:0030431) |
0.2 | 0.2 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.2 | 0.4 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 0.6 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of T cell apoptotic process(GO:0070234) |
0.2 | 5.1 | GO:0006260 | DNA replication(GO:0006260) |
0.2 | 0.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 1.9 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.2 | 0.2 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.2 | 6.9 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.2 | 0.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.2 | 0.4 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.2 | 0.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 3.4 | GO:0051238 | sequestering of metal ion(GO:0051238) |
0.2 | 0.5 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.3 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 0.2 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.2 | 0.5 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 1.0 | GO:0051591 | response to cAMP(GO:0051591) |
0.2 | 1.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 0.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.2 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.2 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 1.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.2 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.2 | 0.2 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.2 | 2.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 0.2 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.2 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.2 | GO:0044409 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.2 | 1.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 0.8 | GO:0031639 | plasminogen activation(GO:0031639) |
0.2 | 24.5 | GO:0006412 | translation(GO:0006412) |
0.2 | 0.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.2 | 0.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 0.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 0.2 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.4 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 2.8 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 0.6 | GO:0072665 | protein localization to vacuole(GO:0072665) |
0.1 | 0.3 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.3 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.6 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.1 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.1 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.5 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.1 | 0.1 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.1 | 0.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:0051851 | modification by host of symbiont morphology or physiology(GO:0051851) |
0.1 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.1 | GO:0019692 | 2'-deoxyribonucleotide metabolic process(GO:0009394) deoxyribose phosphate metabolic process(GO:0019692) |
0.1 | 2.0 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 4.5 | GO:0009615 | response to virus(GO:0009615) |
0.1 | 1.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 1.0 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 3.6 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.1 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.6 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.1 | 0.6 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.8 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.1 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 0.6 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.1 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.1 | 0.8 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.2 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.1 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.6 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.2 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) |
0.1 | 0.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.1 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.1 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.2 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.1 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.1 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 1.9 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 0.2 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.1 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.1 | 1.1 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.2 | GO:0043543 | protein acylation(GO:0043543) |
0.1 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.2 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.7 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.2 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 0.4 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.1 | 0.1 | GO:0070384 | Harderian gland development(GO:0070384) |
0.1 | 1.1 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 0.1 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 0.3 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 3.3 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.1 | 0.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.4 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 15.7 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.1 | 0.1 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.1 | 0.2 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.1 | 0.1 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.1 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.2 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.3 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.1 | 6.6 | GO:0045087 | innate immune response(GO:0045087) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.1 | GO:0034502 | protein localization to chromosome(GO:0034502) |
0.1 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.1 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.0 | GO:0002821 | positive regulation of adaptive immune response(GO:0002821) |
0.0 | 0.0 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.0 | 0.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.0 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.1 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.0 | 0.0 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.0 | 0.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 1.0 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.0 | 0.0 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.0 | 0.0 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.0 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.0 | 0.0 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.0 | 0.0 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.1 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.0 | 0.0 | GO:0009132 | nucleoside diphosphate metabolic process(GO:0009132) |
0.0 | 0.0 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.0 | 0.2 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.0 | 0.1 | GO:0006956 | complement activation(GO:0006956) |
0.0 | 0.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:0072012 | glomerulus vasculature development(GO:0072012) |
0.0 | 0.0 | GO:0031281 | positive regulation of cyclase activity(GO:0031281) positive regulation of lyase activity(GO:0051349) |
0.0 | 0.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.0 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.2 | 65.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
12.9 | 51.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
9.8 | 29.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
9.4 | 37.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
8.6 | 60.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
8.5 | 59.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
8.3 | 83.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
7.7 | 23.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
7.5 | 37.7 | GO:0005638 | lamin filament(GO:0005638) |
7.4 | 67.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
7.4 | 22.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
7.4 | 29.6 | GO:0005642 | annulate lamellae(GO:0005642) |
7.2 | 21.6 | GO:0005712 | chiasma(GO:0005712) |
7.0 | 27.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
6.9 | 62.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
6.7 | 67.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
6.2 | 18.5 | GO:0042585 | germinal vesicle(GO:0042585) |
5.5 | 16.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
5.4 | 86.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
5.2 | 15.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
5.2 | 109.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
5.2 | 41.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
5.0 | 15.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
4.8 | 91.5 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
4.6 | 18.3 | GO:0045298 | tubulin complex(GO:0045298) |
4.5 | 22.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
4.5 | 26.9 | GO:0005818 | aster(GO:0005818) |
4.5 | 13.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
4.5 | 17.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
4.4 | 13.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
4.4 | 31.0 | GO:0032584 | growth cone membrane(GO:0032584) |
4.4 | 26.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
4.3 | 12.9 | GO:0035838 | growing cell tip(GO:0035838) |
4.3 | 17.1 | GO:0098536 | deuterosome(GO:0098536) |
4.2 | 8.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
4.2 | 16.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
4.1 | 28.5 | GO:0005652 | nuclear lamina(GO:0005652) |
3.9 | 31.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
3.9 | 3.9 | GO:0000811 | GINS complex(GO:0000811) |
3.9 | 15.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
3.9 | 50.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
3.8 | 11.5 | GO:0097413 | Lewy body(GO:0097413) |
3.8 | 69.1 | GO:0045120 | pronucleus(GO:0045120) |
3.8 | 26.4 | GO:0042382 | paraspeckles(GO:0042382) |
3.7 | 18.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
3.7 | 22.1 | GO:1990462 | omegasome(GO:1990462) |
3.6 | 10.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
3.6 | 10.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
3.6 | 39.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
3.6 | 25.3 | GO:0070187 | telosome(GO:0070187) |
3.4 | 6.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
3.4 | 13.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
3.4 | 16.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
3.4 | 10.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
3.3 | 10.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
3.3 | 16.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
3.3 | 19.8 | GO:0070820 | tertiary granule(GO:0070820) |
3.3 | 13.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
3.3 | 9.8 | GO:1990923 | PET complex(GO:1990923) |
3.3 | 107.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
3.3 | 13.0 | GO:0000796 | condensin complex(GO:0000796) |
3.2 | 19.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
3.2 | 16.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
3.2 | 12.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
3.1 | 31.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
3.0 | 30.5 | GO:0016580 | Sin3 complex(GO:0016580) |
3.0 | 12.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
3.0 | 26.9 | GO:0036128 | CatSper complex(GO:0036128) |
3.0 | 26.6 | GO:0005869 | dynactin complex(GO:0005869) |
3.0 | 8.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
2.9 | 25.8 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
2.9 | 40.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
2.8 | 11.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
2.8 | 8.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
2.8 | 11.3 | GO:0005955 | calcineurin complex(GO:0005955) |
2.8 | 25.4 | GO:0034709 | methylosome(GO:0034709) |
2.8 | 30.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
2.8 | 5.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
2.8 | 2.8 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.8 | 19.5 | GO:0031931 | TORC1 complex(GO:0031931) |
2.8 | 22.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.7 | 30.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
2.7 | 24.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
2.6 | 5.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
2.6 | 13.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
2.6 | 7.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
2.6 | 2.6 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
2.5 | 7.5 | GO:0005688 | U6 snRNP(GO:0005688) |
2.5 | 12.5 | GO:0071565 | nBAF complex(GO:0071565) |
2.5 | 9.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
2.5 | 22.2 | GO:0097470 | ribbon synapse(GO:0097470) |
2.4 | 114.6 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
2.4 | 7.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
2.4 | 11.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
2.4 | 33.4 | GO:0001891 | phagocytic cup(GO:0001891) |
2.3 | 4.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
2.3 | 9.3 | GO:0071797 | LUBAC complex(GO:0071797) |
2.3 | 203.0 | GO:0030496 | midbody(GO:0030496) |
2.3 | 4.6 | GO:0032127 | dense core granule membrane(GO:0032127) |
2.3 | 16.0 | GO:1990391 | DNA repair complex(GO:1990391) |
2.2 | 17.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
2.2 | 2.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
2.2 | 4.3 | GO:0097255 | R2TP complex(GO:0097255) |
2.1 | 10.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
2.1 | 14.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.1 | 8.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
2.1 | 12.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
2.1 | 20.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
2.1 | 26.9 | GO:0036038 | MKS complex(GO:0036038) |
2.1 | 47.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
2.1 | 12.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
2.1 | 16.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
2.0 | 10.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
2.0 | 28.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
2.0 | 70.8 | GO:0016592 | mediator complex(GO:0016592) |
2.0 | 2.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.0 | 44.9 | GO:0035861 | site of double-strand break(GO:0035861) |
1.9 | 1.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.9 | 9.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.9 | 17.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
1.9 | 32.3 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
1.9 | 125.7 | GO:0034399 | nuclear periphery(GO:0034399) |
1.9 | 22.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.9 | 9.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
1.9 | 5.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.8 | 5.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.8 | 12.8 | GO:0001650 | fibrillar center(GO:0001650) |
1.8 | 14.6 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
1.8 | 11.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.8 | 9.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.8 | 19.9 | GO:0030914 | STAGA complex(GO:0030914) |
1.8 | 19.8 | GO:0032039 | integrator complex(GO:0032039) |
1.8 | 108.1 | GO:0000776 | kinetochore(GO:0000776) |
1.8 | 10.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
1.8 | 12.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.8 | 7.2 | GO:0071817 | MMXD complex(GO:0071817) |
1.8 | 14.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.8 | 71.7 | GO:0005643 | nuclear pore(GO:0005643) |
1.8 | 7.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.8 | 14.2 | GO:0031209 | SCAR complex(GO:0031209) |
1.8 | 7.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.8 | 12.4 | GO:0016272 | prefoldin complex(GO:0016272) |
1.8 | 5.3 | GO:0005745 | m-AAA complex(GO:0005745) |
1.8 | 3.5 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.8 | 5.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.7 | 48.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
1.7 | 5.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.7 | 22.3 | GO:0000786 | nucleosome(GO:0000786) |
1.7 | 20.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.7 | 5.1 | GO:1990635 | proximal dendrite(GO:1990635) |
1.7 | 18.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
1.7 | 11.9 | GO:0042581 | specific granule(GO:0042581) |
1.7 | 8.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.7 | 5.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.7 | 10.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.7 | 5.0 | GO:0042583 | chromaffin granule(GO:0042583) |
1.6 | 19.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.6 | 31.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
1.6 | 44.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.6 | 22.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.6 | 8.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.6 | 42.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
1.6 | 24.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.6 | 55.9 | GO:0045171 | intercellular bridge(GO:0045171) |
1.6 | 7.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.6 | 18.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.6 | 7.8 | GO:0034464 | BBSome(GO:0034464) |
1.6 | 3.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
1.5 | 4.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.5 | 9.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.5 | 6.1 | GO:0035859 | Seh1-associated complex(GO:0035859) |
1.5 | 42.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.5 | 40.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.5 | 7.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.5 | 7.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.5 | 9.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.5 | 519.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
1.5 | 5.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.5 | 4.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.5 | 25.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
1.5 | 26.5 | GO:0034451 | centriolar satellite(GO:0034451) |
1.4 | 11.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.4 | 59.3 | GO:0016605 | PML body(GO:0016605) |
1.4 | 10.1 | GO:0000346 | transcription export complex(GO:0000346) |
1.4 | 43.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.4 | 129.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
1.4 | 5.8 | GO:0032021 | NELF complex(GO:0032021) |
1.4 | 160.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
1.4 | 10.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.4 | 57.2 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
1.4 | 11.4 | GO:0005839 | proteasome core complex(GO:0005839) |
1.4 | 4.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
1.4 | 4.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.4 | 9.8 | GO:0060091 | kinocilium(GO:0060091) |
1.4 | 11.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
1.4 | 18.1 | GO:0000145 | exocyst(GO:0000145) |
1.4 | 12.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.4 | 5.5 | GO:0043219 | lateral loop(GO:0043219) |
1.4 | 10.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.4 | 4.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.4 | 4.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.4 | 9.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.4 | 12.2 | GO:0033391 | chromatoid body(GO:0033391) |
1.3 | 4.0 | GO:0043293 | apoptosome(GO:0043293) |
1.3 | 20.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
1.3 | 1.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.3 | 109.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.3 | 13.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
1.3 | 9.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.3 | 28.8 | GO:0016235 | aggresome(GO:0016235) |
1.3 | 5.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.3 | 29.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.3 | 23.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
1.3 | 8.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.3 | 2.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.3 | 6.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.3 | 2.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.3 | 2.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
1.3 | 6.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.3 | 13.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
1.3 | 20.1 | GO:0005776 | autophagosome(GO:0005776) |
1.2 | 7.4 | GO:0071546 | pi-body(GO:0071546) |
1.2 | 12.2 | GO:0030894 | replisome(GO:0030894) |
1.2 | 2.4 | GO:0034708 | methyltransferase complex(GO:0034708) |
1.2 | 4.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.2 | 10.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.2 | 140.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.2 | 4.8 | GO:0045293 | mRNA editing complex(GO:0045293) |
1.2 | 60.4 | GO:0005814 | centriole(GO:0005814) |
1.2 | 3.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.2 | 3.5 | GO:0010369 | chromocenter(GO:0010369) |
1.2 | 8.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.2 | 18.6 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
1.2 | 4.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.1 | 4.6 | GO:0090544 | BAF-type complex(GO:0090544) |
1.1 | 9.1 | GO:0070652 | HAUS complex(GO:0070652) |
1.1 | 10.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.1 | 12.4 | GO:0002102 | podosome(GO:0002102) |
1.1 | 9.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.1 | 2.2 | GO:0000322 | storage vacuole(GO:0000322) |
1.1 | 4.4 | GO:0031932 | TORC2 complex(GO:0031932) |
1.1 | 3.3 | GO:0097342 | ripoptosome(GO:0097342) |
1.1 | 6.5 | GO:0042587 | glycogen granule(GO:0042587) |
1.1 | 2.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.1 | 7.6 | GO:0000242 | pericentriolar material(GO:0000242) |
1.1 | 2.2 | GO:0016234 | inclusion body(GO:0016234) |
1.1 | 20.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.1 | 19.4 | GO:0030904 | retromer complex(GO:0030904) |
1.1 | 1.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
1.1 | 6.4 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.1 | 2.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
1.1 | 7.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.1 | 24.2 | GO:0012505 | endomembrane system(GO:0012505) |
1.0 | 9.4 | GO:0070852 | cell body fiber(GO:0070852) |
1.0 | 10.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
1.0 | 349.2 | GO:0005694 | chromosome(GO:0005694) |
1.0 | 5.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.0 | 4.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.0 | 4.1 | GO:0070695 | FHF complex(GO:0070695) |
1.0 | 15.4 | GO:0030118 | clathrin coat(GO:0030118) |
1.0 | 9.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.0 | 84.0 | GO:0072562 | blood microparticle(GO:0072562) |
1.0 | 1.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.0 | 3.0 | GO:0070545 | PeBoW complex(GO:0070545) |
1.0 | 14.9 | GO:1902555 | endoribonuclease complex(GO:1902555) |
1.0 | 894.8 | GO:0005739 | mitochondrion(GO:0005739) |
1.0 | 884.3 | GO:0005654 | nucleoplasm(GO:0005654) |
1.0 | 1.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
1.0 | 1.0 | GO:0097422 | tubular endosome(GO:0097422) |
1.0 | 4.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.9 | 1.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.9 | 21.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.9 | 74.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.9 | 91.4 | GO:0005938 | cell cortex(GO:0005938) |
0.9 | 21.6 | GO:0031967 | organelle envelope(GO:0031967) |
0.9 | 27.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.9 | 27.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.9 | 0.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.9 | 7.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.9 | 117.4 | GO:0005813 | centrosome(GO:0005813) |
0.9 | 14.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.9 | 2.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.8 | 10.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.8 | 1.6 | GO:0030286 | dynein complex(GO:0030286) |
0.8 | 3.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.8 | 0.8 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.8 | 2.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.8 | 2.4 | GO:0005840 | ribosome(GO:0005840) |
0.8 | 0.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.8 | 4.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.8 | 0.8 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.8 | 114.9 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.8 | 5.4 | GO:0032420 | stereocilium(GO:0032420) |
0.8 | 11.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.8 | 68.6 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.8 | 1.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.7 | 2.2 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
0.7 | 0.7 | GO:0043656 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.7 | 1.4 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.7 | 4.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.7 | 4.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.7 | 0.7 | GO:0000938 | GARP complex(GO:0000938) |
0.7 | 18.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.7 | 1.3 | GO:0032982 | myosin filament(GO:0032982) |
0.7 | 4.0 | GO:0031415 | NatA complex(GO:0031415) |
0.7 | 2.7 | GO:0042627 | chylomicron(GO:0042627) |
0.6 | 9.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.6 | 33.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.6 | 4.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.6 | 0.6 | GO:0000922 | spindle pole(GO:0000922) |
0.6 | 1.9 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.6 | 3.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.6 | 0.6 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.6 | 19.0 | GO:0005811 | lipid particle(GO:0005811) |
0.6 | 16.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.6 | 1.8 | GO:0031417 | NatC complex(GO:0031417) |
0.6 | 0.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.6 | 5.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.6 | 5.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.6 | 0.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.6 | 2.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.6 | 1.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.6 | 2.8 | GO:0014704 | intercalated disc(GO:0014704) |
0.6 | 5.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.6 | 1.1 | GO:0012506 | vesicle membrane(GO:0012506) |
0.6 | 1.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.5 | 30.0 | GO:0001726 | ruffle(GO:0001726) |
0.5 | 1.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.5 | 0.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.5 | 0.5 | GO:0030120 | vesicle coat(GO:0030120) |
0.5 | 5.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.5 | 0.5 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.5 | 3.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.5 | 3.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 1.5 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 3.5 | GO:0031430 | M band(GO:0031430) |
0.5 | 2.0 | GO:1990745 | EARP complex(GO:1990745) |
0.5 | 2.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 3.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.5 | 13.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 3.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 3.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 5.2 | GO:0097228 | sperm principal piece(GO:0097228) |
0.5 | 8.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.5 | 3.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 5.7 | GO:0005844 | polysome(GO:0005844) |
0.5 | 1.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.5 | 154.2 | GO:0005768 | endosome(GO:0005768) |
0.4 | 1.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 0.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 265.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.4 | 3.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 0.4 | GO:0042827 | platelet dense granule(GO:0042827) |
0.4 | 48.2 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.4 | 3.8 | GO:0036156 | inner dynein arm(GO:0036156) |
0.4 | 2.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 5.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 4.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.4 | 0.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.4 | 2.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 237.2 | GO:0005829 | cytosol(GO:0005829) |
0.4 | 0.4 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.4 | 1.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 6.4 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 0.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.4 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 0.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.3 | 1.2 | GO:1902911 | protein kinase complex(GO:1902911) |
0.3 | 0.3 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.3 | 4.3 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.3 | 1.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 54.8 | GO:0005730 | nucleolus(GO:0005730) |
0.3 | 1.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 4.4 | GO:0005901 | caveola(GO:0005901) |
0.3 | 4.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 747.5 | GO:0005737 | cytoplasm(GO:0005737) |
0.2 | 0.5 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.2 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.2 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 1.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 0.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 9.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 13.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 8.6 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 0.4 | GO:0031090 | organelle membrane(GO:0031090) |
0.0 | 0.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.3 | 65.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
13.2 | 52.8 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
10.5 | 52.7 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
10.4 | 41.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
9.9 | 39.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
9.9 | 29.6 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
9.3 | 18.7 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
8.4 | 33.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
7.9 | 23.7 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
7.7 | 23.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
7.2 | 29.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
7.0 | 34.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
6.9 | 27.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
6.7 | 6.7 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
6.7 | 20.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
6.7 | 153.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
6.6 | 46.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
6.4 | 25.5 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
6.3 | 19.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
6.3 | 19.0 | GO:0004359 | glutaminase activity(GO:0004359) |
6.2 | 24.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
6.0 | 77.4 | GO:0048156 | tau protein binding(GO:0048156) |
5.9 | 17.7 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
5.8 | 23.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
5.6 | 67.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
5.6 | 5.6 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
5.6 | 16.9 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
5.6 | 11.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
5.5 | 21.8 | GO:0036033 | mediator complex binding(GO:0036033) |
5.4 | 21.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
5.4 | 21.6 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
5.4 | 42.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
5.3 | 10.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
5.2 | 31.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
5.1 | 20.4 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
5.0 | 15.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
5.0 | 14.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
4.9 | 24.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
4.9 | 34.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
4.8 | 14.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
4.7 | 23.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
4.7 | 14.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
4.7 | 23.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
4.6 | 41.8 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
4.6 | 18.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
4.5 | 4.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
4.5 | 95.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
4.5 | 17.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
4.4 | 13.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
4.4 | 13.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
4.4 | 17.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
4.4 | 17.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
4.3 | 17.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
4.3 | 21.6 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
4.3 | 17.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
4.2 | 12.7 | GO:0030519 | snoRNP binding(GO:0030519) |
4.2 | 21.2 | GO:0070728 | leucine binding(GO:0070728) |
4.2 | 59.1 | GO:0035173 | histone kinase activity(GO:0035173) |
4.2 | 21.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
4.2 | 58.8 | GO:0005521 | lamin binding(GO:0005521) |
4.1 | 8.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
4.1 | 4.1 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
4.0 | 4.0 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
4.0 | 24.1 | GO:0050733 | RS domain binding(GO:0050733) |
4.0 | 28.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
4.0 | 12.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
4.0 | 63.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
4.0 | 15.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
4.0 | 11.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
3.9 | 19.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
3.9 | 15.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
3.9 | 27.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
3.8 | 11.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
3.8 | 30.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
3.8 | 26.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
3.8 | 26.7 | GO:0018653 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
3.8 | 7.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
3.8 | 11.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
3.8 | 11.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
3.7 | 29.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
3.7 | 11.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
3.7 | 14.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
3.7 | 3.7 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
3.6 | 10.9 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
3.6 | 10.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
3.6 | 25.1 | GO:0060229 | lipase activator activity(GO:0060229) |
3.5 | 17.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
3.5 | 14.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
3.5 | 31.5 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
3.5 | 17.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
3.4 | 20.6 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
3.4 | 13.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
3.4 | 6.8 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
3.3 | 46.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
3.3 | 39.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
3.3 | 6.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
3.3 | 55.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
3.3 | 13.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
3.2 | 6.5 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
3.2 | 9.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
3.2 | 114.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
3.2 | 12.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
3.1 | 3.1 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
3.1 | 6.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
3.1 | 22.0 | GO:0035197 | siRNA binding(GO:0035197) |
3.1 | 37.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
3.1 | 9.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
3.1 | 18.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
3.0 | 15.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
3.0 | 14.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
3.0 | 17.9 | GO:0005536 | glucose binding(GO:0005536) |
3.0 | 6.0 | GO:0055100 | adiponectin binding(GO:0055100) |
3.0 | 8.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
2.9 | 8.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
2.9 | 5.8 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
2.9 | 63.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
2.8 | 14.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
2.8 | 8.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.8 | 14.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
2.8 | 118.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
2.8 | 39.4 | GO:0010181 | FMN binding(GO:0010181) |
2.8 | 8.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
2.8 | 16.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
2.8 | 22.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
2.8 | 16.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
2.8 | 16.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.8 | 19.5 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
2.8 | 27.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
2.7 | 11.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.7 | 10.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
2.7 | 13.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
2.7 | 32.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
2.7 | 8.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
2.7 | 54.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
2.6 | 7.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
2.6 | 15.7 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
2.6 | 18.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.6 | 15.6 | GO:0034046 | poly(G) binding(GO:0034046) |
2.6 | 15.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
2.6 | 12.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
2.6 | 33.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
2.6 | 7.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
2.5 | 12.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
2.5 | 12.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
2.5 | 7.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
2.5 | 79.9 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
2.5 | 10.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
2.5 | 7.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
2.5 | 29.9 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
2.5 | 7.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
2.5 | 7.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
2.5 | 19.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
2.5 | 7.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
2.5 | 7.4 | GO:0004103 | choline kinase activity(GO:0004103) |
2.5 | 9.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
2.4 | 36.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
2.4 | 24.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
2.4 | 14.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.4 | 14.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.4 | 12.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
2.4 | 81.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
2.4 | 7.1 | GO:2001069 | glycogen binding(GO:2001069) |
2.4 | 61.2 | GO:0045502 | dynein binding(GO:0045502) |
2.3 | 35.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
2.3 | 7.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
2.3 | 20.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.3 | 4.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
2.3 | 2.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
2.3 | 6.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
2.3 | 2.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.2 | 6.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
2.2 | 24.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
2.2 | 6.7 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
2.2 | 44.7 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
2.2 | 22.3 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
2.2 | 6.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
2.2 | 4.4 | GO:2001070 | starch binding(GO:2001070) |
2.2 | 6.6 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.2 | 15.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
2.2 | 34.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
2.1 | 40.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
2.1 | 6.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
2.1 | 44.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
2.1 | 12.8 | GO:0008199 | ferric iron binding(GO:0008199) |
2.1 | 6.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
2.1 | 6.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.1 | 6.3 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
2.1 | 4.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
2.1 | 6.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
2.1 | 53.5 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
2.1 | 26.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
2.0 | 28.4 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
2.0 | 16.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
2.0 | 22.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
2.0 | 20.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
2.0 | 12.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
2.0 | 10.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
2.0 | 40.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
2.0 | 2.0 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
2.0 | 8.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
2.0 | 4.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
2.0 | 9.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
2.0 | 11.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
2.0 | 9.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.0 | 25.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
2.0 | 5.9 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
2.0 | 5.9 | GO:0048030 | disaccharide binding(GO:0048030) |
2.0 | 3.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
2.0 | 5.9 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.9 | 38.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.9 | 38.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
1.9 | 48.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
1.9 | 11.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.9 | 9.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
1.9 | 15.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.9 | 7.5 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
1.9 | 1.9 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
1.9 | 9.4 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.9 | 9.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.9 | 3.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.9 | 7.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.9 | 5.6 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.8 | 5.5 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
1.8 | 9.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.8 | 12.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.8 | 5.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.8 | 7.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.8 | 5.5 | GO:0019862 | IgA binding(GO:0019862) |
1.8 | 3.6 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
1.8 | 5.4 | GO:0004064 | arylesterase activity(GO:0004064) |
1.8 | 30.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
1.8 | 5.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.8 | 8.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.8 | 5.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.8 | 1.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.8 | 5.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.7 | 21.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.7 | 1.7 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.7 | 106.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.7 | 5.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.7 | 18.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.7 | 5.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.7 | 5.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.7 | 24.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
1.7 | 5.0 | GO:0000182 | rDNA binding(GO:0000182) |
1.6 | 6.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.6 | 32.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
1.6 | 4.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.6 | 16.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.6 | 144.6 | GO:0042393 | histone binding(GO:0042393) |
1.6 | 16.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.6 | 4.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.6 | 3.2 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
1.6 | 8.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
1.6 | 24.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.6 | 6.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.6 | 1.6 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
1.6 | 43.1 | GO:0015485 | cholesterol binding(GO:0015485) |
1.6 | 4.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.6 | 4.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.6 | 7.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
1.6 | 50.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.6 | 3.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.6 | 25.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.6 | 22.0 | GO:0031489 | myosin V binding(GO:0031489) |
1.6 | 18.8 | GO:0005542 | folic acid binding(GO:0005542) |
1.6 | 6.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.6 | 3.1 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.6 | 25.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.6 | 18.6 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
1.5 | 12.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
1.5 | 35.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
1.5 | 18.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.5 | 3.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.5 | 10.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
1.5 | 50.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
1.5 | 6.1 | GO:0043559 | insulin binding(GO:0043559) |
1.5 | 6.1 | GO:0019808 | polyamine binding(GO:0019808) |
1.5 | 4.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.5 | 7.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.5 | 9.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.5 | 10.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.5 | 26.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
1.5 | 1.5 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
1.5 | 25.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.5 | 4.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.5 | 8.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.5 | 5.8 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
1.5 | 30.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.5 | 1.5 | GO:0051380 | norepinephrine binding(GO:0051380) |
1.5 | 7.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.5 | 10.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.5 | 2.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.4 | 11.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.4 | 40.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.4 | 14.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.4 | 5.7 | GO:0005522 | profilin binding(GO:0005522) |
1.4 | 34.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
1.4 | 9.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.4 | 19.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.4 | 11.2 | GO:0034871 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.4 | 8.4 | GO:0015288 | porin activity(GO:0015288) |
1.4 | 15.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
1.4 | 48.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
1.4 | 66.7 | GO:0051087 | chaperone binding(GO:0051087) |
1.4 | 34.5 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
1.4 | 4.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
1.4 | 8.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
1.4 | 9.5 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
1.4 | 12.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.4 | 6.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
1.4 | 14.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
1.4 | 10.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.4 | 4.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.3 | 21.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
1.3 | 24.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.3 | 4.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
1.3 | 4.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.3 | 19.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.3 | 24.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.3 | 3.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.3 | 18.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.3 | 11.7 | GO:0031386 | protein tag(GO:0031386) |
1.3 | 24.7 | GO:0030506 | ankyrin binding(GO:0030506) |
1.3 | 6.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.3 | 13.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.3 | 11.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
1.3 | 43.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
1.3 | 16.8 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
1.3 | 33.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
1.3 | 3.8 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
1.3 | 23.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
1.3 | 6.4 | GO:0008430 | selenium binding(GO:0008430) |
1.3 | 8.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.3 | 14.0 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
1.3 | 7.6 | GO:0050700 | CARD domain binding(GO:0050700) |
1.3 | 1.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
1.3 | 8.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.2 | 17.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.2 | 2.5 | GO:0030911 | TPR domain binding(GO:0030911) |
1.2 | 1.2 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
1.2 | 13.6 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
1.2 | 3.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.2 | 3.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.2 | 8.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
1.2 | 4.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.2 | 2.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
1.2 | 3.6 | GO:0015556 | L-aspartate transmembrane transporter activity(GO:0015183) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
1.2 | 3.5 | GO:0097016 | L27 domain binding(GO:0097016) |
1.2 | 2.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.2 | 3.5 | GO:0016151 | nickel cation binding(GO:0016151) |
1.2 | 4.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.2 | 7.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
1.2 | 37.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
1.2 | 6.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.2 | 3.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.2 | 15.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.1 | 16.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.1 | 3.4 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
1.1 | 22.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
1.1 | 3.4 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.1 | 13.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
1.1 | 4.5 | GO:0042731 | PH domain binding(GO:0042731) |
1.1 | 5.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.1 | 14.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
1.1 | 4.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.1 | 2.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.1 | 7.8 | GO:0030371 | translation repressor activity(GO:0030371) |
1.1 | 1.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.1 | 1.1 | GO:0034618 | arginine binding(GO:0034618) |
1.1 | 7.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.1 | 14.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.1 | 7.6 | GO:0045545 | syndecan binding(GO:0045545) |
1.1 | 5.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.1 | 2.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.1 | 2.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
1.1 | 56.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
1.1 | 9.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.1 | 21.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.1 | 69.1 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.1 | 4.2 | GO:0030955 | potassium ion binding(GO:0030955) |
1.1 | 3.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.0 | 21.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.0 | 9.3 | GO:0070628 | proteasome binding(GO:0070628) |
1.0 | 2.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.0 | 1.0 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
1.0 | 41.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
1.0 | 23.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
1.0 | 63.7 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
1.0 | 9.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.0 | 2.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.0 | 5.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.0 | 3.0 | GO:0030275 | LRR domain binding(GO:0030275) |
1.0 | 3.0 | GO:0089720 | caspase binding(GO:0089720) |
1.0 | 4.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.0 | 2.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.0 | 1.0 | GO:0051379 | alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
1.0 | 11.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
1.0 | 2.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.0 | 2.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
1.0 | 2.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.9 | 1.9 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.9 | 11.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.9 | 18.0 | GO:0030145 | manganese ion binding(GO:0030145) |
0.9 | 18.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.9 | 4.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.9 | 10.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.9 | 2.8 | GO:0019002 | GMP binding(GO:0019002) |
0.9 | 4.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.9 | 6.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.9 | 7.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.9 | 1.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.9 | 20.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.9 | 2.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.9 | 5.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.9 | 105.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.9 | 3.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.9 | 218.2 | GO:0005525 | GTP binding(GO:0005525) |
0.9 | 7.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.9 | 2.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.9 | 6.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.9 | 11.4 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.9 | 2.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.9 | 12.0 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.9 | 8.6 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.9 | 1.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.9 | 9.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.9 | 17.9 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.9 | 3.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.9 | 7.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.8 | 2.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.8 | 2.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.8 | 4.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.8 | 2.5 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.8 | 5.9 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.8 | 1.7 | GO:0038100 | nodal binding(GO:0038100) |
0.8 | 44.9 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.8 | 3.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.8 | 148.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.8 | 10.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.8 | 12.1 | GO:0005112 | Notch binding(GO:0005112) |
0.8 | 0.8 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
0.8 | 3.2 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.8 | 17.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.8 | 2.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.8 | 1.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.8 | 2.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.8 | 31.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.8 | 1.6 | GO:0005534 | galactose binding(GO:0005534) |
0.8 | 17.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.8 | 20.9 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.8 | 3.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.8 | 3.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.8 | 2.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.8 | 2.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.8 | 5.3 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.8 | 6.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.7 | 3.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.7 | 3.0 | GO:0035473 | lipase binding(GO:0035473) |
0.7 | 10.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.7 | 1.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.7 | 30.7 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.7 | 2.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.7 | 1.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.7 | 28.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.7 | 1.4 | GO:0051998 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.7 | 511.1 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.7 | 20.6 | GO:0001067 | regulatory region nucleic acid binding(GO:0001067) |
0.7 | 1.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.7 | 2.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.7 | 2.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.7 | 3.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.7 | 2.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.7 | 0.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.7 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
0.7 | 4.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.7 | 1.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.7 | 2.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.7 | 11.3 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.7 | 2.6 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.7 | 2.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.7 | 2.6 | GO:0043786 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.7 | 3.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.7 | 2.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.6 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.6 | 5.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.6 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 0.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.6 | 22.6 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.6 | 3.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.6 | 6.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.6 | 10.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.6 | 1.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.6 | 9.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 1.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.6 | 0.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.6 | 1.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.6 | 1.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.6 | 4.1 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.6 | 2.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.6 | 4.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.6 | 2.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.6 | 52.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.6 | 24.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.6 | 4.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.6 | 1.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.6 | 2.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 42.1 | GO:0020037 | heme binding(GO:0020037) |
0.6 | 17.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.6 | 5.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.6 | 2.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.6 | 1.7 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.6 | 15.6 | GO:0051723 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) protein methylesterase activity(GO:0051723) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.6 | 4.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.6 | 2.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 15.4 | GO:0019902 | phosphatase binding(GO:0019902) |
0.6 | 2.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.5 | 3.3 | GO:0001135 | transcription factor activity, transcription factor recruiting(GO:0001134) transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.5 | 6.5 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.5 | 1.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.5 | 1.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.5 | 0.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.5 | 10.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.5 | 3.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.5 | 3.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 2.6 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.5 | 36.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.5 | 2.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.5 | 1.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.5 | 3.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 1.5 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.5 | 1.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.5 | 1.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.5 | 9.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.5 | 2.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.5 | 0.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.5 | 3.9 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.5 | 2.9 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.5 | 1.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.5 | 4.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.5 | 8.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.5 | 1.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.5 | 1.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.5 | 9.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.5 | 1.4 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.5 | 7.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.5 | 1.9 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.5 | 3.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.5 | 3.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.5 | 4.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.5 | 5.5 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.5 | 2.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.5 | 1.8 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.5 | 0.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.5 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 6.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 1.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 1.8 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.4 | 0.4 | GO:0035877 | death effector domain binding(GO:0035877) |
0.4 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 19.4 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.4 | 0.4 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 2.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 5.7 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.4 | 0.9 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 1.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.4 | 1.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.4 | 22.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.4 | 2.5 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.4 | 1.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.4 | 4.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 87.5 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.4 | 1.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 5.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.4 | 8.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.4 | 5.8 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.4 | 2.9 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.4 | 0.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.4 | 22.1 | GO:0002020 | protease binding(GO:0002020) |
0.4 | 1.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 1.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.4 | 26.6 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.4 | 1.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 0.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 9.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 0.4 | GO:0009374 | biotin binding(GO:0009374) |
0.4 | 0.8 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.4 | 1.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 2.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.4 | 0.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 25.9 | GO:0015405 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
0.4 | 0.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 0.7 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 3.7 | GO:0016209 | antioxidant activity(GO:0016209) |
0.4 | 1.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 2.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 1.7 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.3 | 0.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 17.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 1.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 0.3 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.3 | 0.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 1.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 22.5 | GO:0008017 | microtubule binding(GO:0008017) |
0.3 | 4.4 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 0.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 5.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 0.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 0.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 0.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 1.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 0.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 5.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.3 | 0.9 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.3 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 1.2 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 2.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 0.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 0.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 2.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 9.6 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.3 | 3.2 | GO:0019239 | deaminase activity(GO:0019239) |
0.3 | 1.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 1.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 0.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 7.3 | GO:0016791 | phosphatase activity(GO:0016791) |
0.3 | 6.4 | GO:0016874 | ligase activity(GO:0016874) |
0.3 | 0.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 2.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 1.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 2.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 1.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 14.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 3.7 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.3 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 0.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 4.1 | GO:0005504 | fatty acid binding(GO:0005504) |
0.3 | 25.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 0.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 0.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 0.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 0.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 0.3 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.3 | 0.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 0.7 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.2 | 3.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.5 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.2 | 1.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 2.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 1.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 9.8 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 1.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 2.2 | GO:0005506 | iron ion binding(GO:0005506) |
0.2 | 0.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.9 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.2 | 1.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 1.5 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 121.1 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 1.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 2.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 4.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 1.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 2.9 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.2 | 24.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.2 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.2 | 0.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 0.3 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.2 | 2.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.2 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 24.5 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 2.8 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 0.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 1.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 2.5 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.2 | 1.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 2.7 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 1.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.6 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 1.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 2.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.7 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.1 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.1 | 0.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.0 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 1.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 31.8 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 35.3 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 1.2 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.1 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 1.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 11.9 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 2.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.1 | GO:0016415 | O-octanoyltransferase activity(GO:0016414) octanoyltransferase activity(GO:0016415) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.2 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 0.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 1.3 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 1.4 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 2.0 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 1.5 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 1.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.8 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.6 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 3.4 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.0 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 3.8 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.0 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.0 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 29.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.7 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.0 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 50.8 | ST STAT3 PATHWAY | STAT3 Pathway |
5.6 | 134.2 | PID MYC PATHWAY | C-MYC pathway |
5.3 | 58.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
4.7 | 170.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
4.3 | 68.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
4.1 | 44.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
3.6 | 108.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
3.6 | 10.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
3.3 | 113.7 | PID AURORA B PATHWAY | Aurora B signaling |
3.3 | 29.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
3.2 | 35.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
3.2 | 57.8 | PID BARD1 PATHWAY | BARD1 signaling events |
3.1 | 68.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
3.1 | 70.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
2.9 | 38.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
2.8 | 16.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
2.8 | 42.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
2.8 | 58.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
2.7 | 46.7 | PID ARF 3PATHWAY | Arf1 pathway |
2.7 | 98.2 | PID P53 REGULATION PATHWAY | p53 pathway |
2.7 | 134.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
2.5 | 47.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
2.4 | 82.9 | PID INSULIN PATHWAY | Insulin Pathway |
2.4 | 9.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.4 | 24.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
2.4 | 14.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
2.3 | 4.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
2.3 | 4.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
2.3 | 13.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
2.2 | 65.7 | PID PLK1 PATHWAY | PLK1 signaling events |
2.2 | 10.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
2.1 | 12.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
2.1 | 45.7 | PID RHOA PATHWAY | RhoA signaling pathway |
2.0 | 26.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.9 | 9.6 | PID FOXO PATHWAY | FoxO family signaling |
1.9 | 49.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.9 | 22.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
1.9 | 18.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.9 | 85.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.8 | 25.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.8 | 31.0 | ST GAQ PATHWAY | G alpha q Pathway |
1.7 | 5.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.7 | 12.1 | PID IGF1 PATHWAY | IGF1 pathway |
1.7 | 20.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.7 | 11.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.7 | 1.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.6 | 49.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.6 | 18.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.6 | 12.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.5 | 24.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.5 | 28.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.5 | 13.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.5 | 115.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.5 | 55.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.4 | 4.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.3 | 23.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.3 | 23.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.2 | 3.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.2 | 39.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.2 | 37.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.2 | 12.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.2 | 15.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.1 | 25.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.1 | 30.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
1.1 | 15.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.1 | 6.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.1 | 21.6 | PID BCR 5PATHWAY | BCR signaling pathway |
1.1 | 22.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.1 | 32.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
1.0 | 11.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.0 | 4.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.0 | 20.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
1.0 | 8.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.0 | 1.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.9 | 5.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.9 | 12.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.9 | 19.5 | PID P73PATHWAY | p73 transcription factor network |
0.9 | 2.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.9 | 14.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.8 | 6.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.8 | 10.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.8 | 11.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.8 | 6.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.8 | 14.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.8 | 9.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.8 | 8.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.8 | 8.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.7 | 8.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.7 | 6.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.7 | 0.7 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.7 | 1.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.7 | 5.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.7 | 7.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.7 | 17.6 | PID E2F PATHWAY | E2F transcription factor network |
0.6 | 1.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.6 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 8.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.6 | 3.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.6 | 7.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 4.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 4.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 6.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 10.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.5 | 0.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.5 | 8.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 3.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 13.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 5.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 3.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.4 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 2.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 1.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.4 | 6.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.4 | 3.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 6.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 7.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.3 | 1.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 5.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 3.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 6.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 4.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.3 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 2.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 1.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 2.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 1.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 0.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 2.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 1.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 4.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 3.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 2.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 4.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.0 | 55.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
7.3 | 58.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
7.0 | 118.8 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
6.2 | 6.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
6.0 | 119.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
5.5 | 49.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
5.5 | 65.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
5.2 | 104.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
5.2 | 10.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
5.2 | 52.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
4.8 | 24.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
4.8 | 71.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
4.7 | 9.3 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
4.5 | 49.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
4.5 | 62.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
4.4 | 17.8 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
4.3 | 68.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
4.3 | 17.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
4.0 | 11.9 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
3.9 | 39.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
3.9 | 19.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
3.8 | 11.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
3.7 | 37.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
3.6 | 32.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
3.3 | 53.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
3.3 | 40.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
3.3 | 23.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
3.3 | 215.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
3.3 | 26.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
3.2 | 35.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
3.2 | 31.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
3.1 | 6.3 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
3.1 | 34.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
3.1 | 15.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
3.1 | 3.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
3.1 | 67.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
3.0 | 27.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
3.0 | 32.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
2.9 | 35.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
2.9 | 76.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
2.9 | 34.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
2.9 | 54.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
2.9 | 40.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
2.8 | 112.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
2.8 | 33.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
2.7 | 56.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
2.7 | 5.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
2.5 | 10.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
2.5 | 15.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
2.5 | 12.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
2.5 | 29.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
2.5 | 44.6 | REACTOME KINESINS | Genes involved in Kinesins |
2.5 | 46.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
2.4 | 24.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.4 | 7.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.4 | 19.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.4 | 59.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
2.3 | 58.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
2.3 | 62.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
2.3 | 97.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
2.3 | 36.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
2.3 | 6.8 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
2.2 | 20.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
2.2 | 21.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
2.1 | 38.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
2.1 | 48.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
2.1 | 18.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
2.1 | 194.0 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
2.1 | 29.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
2.0 | 17.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
2.0 | 21.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
2.0 | 39.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
2.0 | 25.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.9 | 42.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
1.9 | 9.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.9 | 19.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.9 | 5.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.8 | 11.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.8 | 47.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
1.8 | 55.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.8 | 27.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.8 | 32.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
1.8 | 9.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.8 | 35.5 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
1.8 | 23.0 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
1.8 | 8.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.7 | 40.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.7 | 25.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
1.7 | 10.0 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
1.7 | 6.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.7 | 10.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.6 | 1.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
1.6 | 1.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.6 | 27.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.6 | 14.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.6 | 69.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
1.6 | 34.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.6 | 17.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.6 | 20.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
1.5 | 3.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.5 | 33.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.5 | 40.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.5 | 36.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.5 | 21.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.5 | 52.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.5 | 25.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.5 | 95.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.5 | 27.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.4 | 93.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.4 | 18.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.4 | 18.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.3 | 10.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.3 | 14.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.3 | 14.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.3 | 19.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.3 | 17.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.3 | 52.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.2 | 33.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.2 | 9.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.2 | 152.1 | REACTOME TRANSLATION | Genes involved in Translation |
1.2 | 34.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.2 | 7.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.2 | 7.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.2 | 24.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
1.2 | 3.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
1.2 | 52.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
1.1 | 11.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.1 | 16.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
1.1 | 17.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
1.1 | 11.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.1 | 13.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.1 | 10.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.1 | 13.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
1.0 | 1.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.0 | 6.1 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
1.0 | 8.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.0 | 11.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
1.0 | 1.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.0 | 26.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.0 | 10.5 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
1.0 | 4.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.9 | 20.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.9 | 38.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.9 | 12.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.9 | 4.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.9 | 2.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.9 | 6.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.9 | 17.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.9 | 9.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.9 | 0.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.9 | 9.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.9 | 14.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.9 | 8.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.9 | 24.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.9 | 7.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.9 | 7.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.9 | 10.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.9 | 9.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.9 | 11.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.8 | 7.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.8 | 9.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.8 | 1.7 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.8 | 9.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.8 | 9.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.8 | 12.3 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.7 | 4.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.7 | 81.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.7 | 8.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.7 | 5.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.7 | 7.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.7 | 10.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.7 | 18.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.6 | 5.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.6 | 0.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.6 | 4.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.6 | 0.6 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.6 | 0.6 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.6 | 16.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.6 | 3.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.6 | 2.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.6 | 11.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 52.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.6 | 9.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.6 | 0.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.6 | 1.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 3.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.5 | 1.1 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.5 | 31.5 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.5 | 21.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.5 | 3.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 2.2 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.4 | 5.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 18.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 15.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.4 | 2.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 6.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 4.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 2.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 0.3 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.3 | 0.8 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.3 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.3 | 1.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 1.3 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.3 | 1.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 0.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 1.3 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.3 | 0.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 5.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 0.2 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 4.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 3.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 1.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 0.2 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.2 | 0.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 1.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 3.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 0.9 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 0.3 | REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL | Genes involved in Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell |
0.2 | 5.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 4.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.6 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.1 | 0.4 | REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION | Genes involved in TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
0.1 | 1.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.7 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.1 | REACTOME CELL CYCLE MITOTIC | Genes involved in Cell Cycle, Mitotic |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 2.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |